Rosacea

L12_ROSACEA

rosacea: a chronic skin condition characterized by facial redness, small and superficial dilated blood vessels on facial skin, papules, pustules, and swelling.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — L71 Cause of death: ICD-10 — L71 2 out of 7 registries used, show all original rules.	6405
4. Check minimum number of events None	6405
5. Include endpoints L12_PERIORALDERM L12_RHINOPHYMA L12_ROSACEANAS	6437
6. Filter based on genotype QC (FinnGen only)	5872

Control definitions (FinnGen only)

Control exclude: L12_DISORDSKINAPPENDIX

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: L60-L75
Name in latin: Rosacea

NAME	L12_ROSACEA
CONTROL_EXCLUDE	L12_DISORDSKINAPPENDIX
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	L12_PERIORALDERM\|L12_RHINOPHYMA\|L12_ROSACEANAS
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	L71
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	L71
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Rosacea based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	5872	4349	1523
Unadjusted period prevalence (%)	1.32	1.54	0.70
Median age at first event (years)	55.94	53.49	62.92

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
6029: Matched controls
60290

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

L71.8

ICD-10 Finland

Other rosacea

198.8

307.7

2234

178

E0000UV, ,

ATC

3.3

307.7

3662

19357

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

4.4

307.7

1025

2680

J01AA07

ATC

tetracycline; systemic

6.2

307.7

2311

5461

D06BX01

ATC

metronidazole; topical

25.6

307.7

3805

3774

L71

ICD-10 Finland

Rosacea

37.2

307.7

1689

624

J01AA04

ATC

lymecycline; systemic

9.8

307.7

2701

4602

D10BA01

ATC

isotretinoin; oral

8.6

307.7

1222

1732

L71.9

ICD-10 Finland

Rosacea, unspecified

98.9

307.7

2696

489

D10AX03

ATC

azelaic acid; topical

5.4

307.7

1138

2481

L71.0

ICD-10 Finland

Perioral dermatitis

34.8

307.7

1115

390

L30.9

ICD-10 Finland

Dermatitis, unspecified

2.8

278.0

1968

8915

XQ802

NOMESCO Finland

Epicutan test

5.1

261.7

596

1281

L71.1

ICD-10 Finland

Rhinophyma

352.3

238.1

239

L70.0

ICD-10 Finland

Acne vulgaris

8.8

230.1

294

348

E000001, ,

ATC

2.6

205.4

1627

7622

L57.0

ICD-10 Finland

Actinic keratosis

3.3

203.4

864

2894

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

3.1

200.8

956

3427

XQ848

NOMESCO Finland

Dermatological photography

5.6

178.9

349

650

D07AB02

ATC

hydrocortisone butyrate; topical

2.1

156.2

2188

12788

L73.8

ICD-10 Finland

Other specified follicular disorders

15.3

150.5

132

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

2.0

141.7

2928

19488

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

2.1

138.1

1664

9103

XQ800

NOMESCO Finland

Prick test

2.9

137.7

709

2627

D07AC01

ATC

betamethasone; topical

2.0

136.7

2521

16076

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

5.8

133.7

249

443

H04.10

ICD-10 Finland

Dry eye syndrome

2.4

124.9

1014

4690

L21.8

ICD-10 Finland

Other seborrhoeic dermatitis

7.2

115.9

174

248

D07AC13

ATC

mometasone; topical

1.9

114.6

1975

12137

S01GX01

ATC

cromoglicic acid; ophthalmic

2.0

110.3

1547

8838

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

2.3

110.0

999

4829

L21.9

ICD-10 Finland

Seborrhoeic dermatitis, unspecified

5.1

109.0

234

473

H01.0

ICD-10 Finland

Blepharitis

2.7

103.1

621

2483

D07AD01

ATC

clobetasol; topical

2.1

101.3

1223

6594

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

4.5

97.9

242

550

D07XC01

ATC

betamethasone; topical

2.3

97.6

841

3962

D07AB08

ATC

desonide; topical

2.3

92.4

791

3711

E0001A1, ,

ATC

4.7

90.7

215

472

TQW80

NOMESCO Finland

Local dermatologic skincare

4.2

88.9

241

588

R06AX27

ATC

desloratadine; oral

1.8

87.4

2069

13775

XQ845

NOMESCO Finland

Dermatoscopy

5.0

87.1

192

397

D10AF01

ATC

clindamycin; topical

2.9

83.8

409

1459

H02AB06

ATC

prednisolone; systemic

1.7

83.3

2955

21887

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

4.7

82.5

196

431

L73.2

ICD-10 Finland

Hidradenitis suppurativa

12.7

80.3

L20.0

ICD-10 Finland

Besnier prurigo

2.4

78.9

611

2736

J02AC01

ATC

fluconazole; systemic

1.7

78.9

2783

20483

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.7

77.7

1918

12826

L70

ICD-10 Finland

Acne

5.0

76.9

166

337

R06AE07

ATC

cetirizine; oral

1.6

74.8

2884

21607

ZXC50

NOMESCO Finland

Cryotherapy

3.8

74.7

231

620

E000002, ,

ATC

2.1

73.3

771

3908

S29

ICPC

Skin symptom/complaint other

1.8

68.4

1332

8278

L04AX01

ATC

azathioprine; systemic

2.9

67.6

336

1209

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

2.8

66.8

344

1261

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

2.4

66.7

515

2298

ZXC12

NOMESCO Finland

Pulse colorlaser

12.6

66.6

D07AA02

ATC

hydrocortisone; topical

1.9

65.7

922

5166

L70.8

ICD-10 Finland

Other acne

18.7

65.7

L40.0

ICD-10 Finland

Psoriasis vulgaris

2.9

64.9

322

1157

H01.80

ICD-10 Finland

Prolonged inflammation in the edge of the eyelid

5.8

64.2

118

207

H00.1

ICD-10 Finland

Chalazion

2.9

64.2

320

1153

L23.2

ICD-10 Finland

Allergic contact dermatitis due to cosmetics

5.4

63.6

126

237

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

2.6

62.4

393

1595

D02AE01

ATC

carbamide; topical

2.4

62.2

454

1974

L73.9

ICD-10 Finland

Follicular disorder, unspecified

10.6

62.1

D11AH02

ATC

pimecrolimus; topical

8.5

58.3

QAA40

NOMESCO Finland

Laser therapy or photocoagulation of skin of head or neck

9.4

58.0

L04AX03

ATC

methotrexate; systemic

2.0

57.7

667

3485

R06AE09

ATC

levocetirizine; oral

1.8

57.2

986

5875

L21.0

ICD-10 Finland

Seborrhoea capitis

5.6

57.0

108

195

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.6

56.9

1694

11703

L82

ICD-10 Finland

Seborrhoeic keratosis

1.7

56.6

1183

7451

J01DB01

ATC

cefalexin; oral

1.7

56.6

4988

44187

L93.0

ICD-10 Finland

Discoid lupus erythematosus

7.9

56.1

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.7

55.0

1364

8986

L50.3

ICD-10 Finland

Dermatographic urticaria

3.7

53.1

168

458

L70.9

ICD-10 Finland

Acne, unspecified

8.4

52.2

D02AX

ATC

Other emollients and protectives

3.0

52.1

234

795

D07BA04

ATC

hydrocortisone and antiseptics; topical

2.0

52.0

627

3320

UJF32

NOMESCO Finland

Coloscopy

1.6

51.6

1484

10123

P01BA02

ATC

hydroxychloroquine; oral

2.0

48.7

566

2955

TQW99

NOMESCO Finland

Other minor procedure on skin

2.6

48.2

302

1221

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

2.2

47.8

430

2038

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

2.4

47.7

352

1534

S18

ICPC

Laceration/cut

1.5

47.7

2675

21037

J01AA02

ATC

doxycycline; systemic

1.6

47.3

4619

40668

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

47.1

1382

9440

A06AC01

ATC

ispaghula (psylla seeds); oral

1.6

45.9

1554

10965

L21

ICD-10 Finland

Seborrhoeic dermatitis

3.6

45.1

148

414

R01AD12

ATC

fluticasone furoate; nasal

1.5

44.6

2037

15307

I78.9

ICD-10 Finland

Disease of capillaries, unspecified

9.9

43.6

S01XA18

ATC

ciclosporin; ophthalmic

5.3

43.5

169

SPAT1153

SPAT

Removal of sutures

1.5

42.8

1703

12412

A02BC05

ATC

esomeprazole; systemic

1.5

42.5

2379

18569

L30.8

ICD-10 Finland

Other specified dermatitis

2.8

42.4

215

781

317

Kela drug reimbursment

Topical pimecrolimus and tacrolimus

3.6

41.9

141

401

E000007, ,

ATC

2.2

41.4

364

1708

R01AD58

ATC

fluticasone, combinations; nasal

1.5

41.3

1641

11939

L04AA06

ATC

mycophenolic acid; systemic

3.5

40.6

144

424

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.7

40.6

755

4567

M79.6

ICD-10 Finland

Pain in limb

1.4

40.5

2682

21542

R06AX22

ATC

ebastine; oral

1.6

39.6

1090

7297

D05BB02

ATC

acitretin; oral

3.2

38.6

152

478

J04BA02

ATC

dapsone; oral

7.5

38.6

J05AB01

ATC

aciclovir; systemic

1.5

38.4

1329

9364

E000006, ,

ATC

2.0

38.4

419

2135

J01FA10

ATC

azithromycin; systemic

1.4

37.8

3477

29479

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.4

37.4

2523

20234

WXQ27

NOMESCO Finland

UVB narrow spectrum light therapy

4.1

37.4

104

259

J02AC02

ATC

itraconazole; systemic

1.6

37.4

1072

7236

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.6

37.1

1009

6725

L72.1

ICD-10 Finland

Trichilemmal cyst

2.2

36.9

319

1486

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

36.3

1860

14164

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

2.5

36.1

237

979

R01AD08

ATC

fluticasone; nasal

1.5

34.8

1716

12952

S99

ICPC

Skin disease other

3.0

34.6

158

542

R01AD09

ATC

mometasone; nasal

1.4

34.6

2764

22723

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

3.6

34.6

115

325

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.4

34.4

2207

17466

M25.5

ICD-10 Finland

Pain in joint

1.4

34.3

2043

15956

R03AC02

ATC

salbutamol; inhalant

1.4

33.8

3252

27540

H10.4

ICD-10 Finland

Chronic conjunctivitis

4.3

33.7

209

D05AX52

ATC

calcipotriol, combinations; topical

2.1

33.7

316

1520

ZXC15

NOMESCO Finland

Use of photodynamic technique

4.4

33.6

193

L23.0

ICD-10 Finland

Allergic contact dermatitis due to metals

3.9

33.3

250

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.5

33.0

1096

7622

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.7

33.0

647

3958

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.9

32.5

433

2360

A02BC03

ATC

lansoprazole; oral

1.5

32.1

1528

11420

J01FF01

ATC

clindamycin; systemic

1.5

31.7

1488

11091

H02AB04

ATC

methylprednisolone; systemic

1.6

31.6

818

5371

CBB00

NOMESCO Finland

Excision of chalazion

3.7

31.6

269

A02BC02

ATC

pantoprazole; systemic

1.4

31.4

3941

34668

R03DC03

ATC

montelukast; oral

1.5

31.2

1020

7063

J01DA01

ATC

[U] cefalexin

1.4

30.9

3493

30164

D06BB10

ATC

imiquimod; topical

2.1

30.4

311

1545

L30.3

ICD-10 Finland

Infective dermatitis

2.3

30.3

226

989

J01MA02

ATC

ciprofloxacin; systemic

1.4

30.2

2025

16050

S21

ICPC

Skin texture symptom/complaint

1.6

30.1

860

5772

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.4

30.1

1585

12046

D11AH01

ATC

tacrolimus; topical

3.8

30.0

237

H10.5

ICD-10 Finland

Blepharoconjunctivitis

2.8

29.8

147

527

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

2.9

29.7

144

511

A02BC01

ATC

omeprazole; systemic

1.4

29.4

1454

10918

F29

ICPC

Eye symptom/complaint other

1.7

29.4

642

4038

H02AB07

ATC

prednisone; oral

1.6

29.1

732

4766

R07.4

ICD-10 Finland

Chest pain, unspecified

1.4

29.0

1488

11244

J31.0

ICD-10 Finland

Chronic rhinitis

1.7

28.5

531

3200

H00.00

ICD-10 Finland

Hordeolum

2.0

28.1

302

1529

R06AX13

ATC

loratadine; oral

1.5

27.9

899

6192

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

2.1

27.5

270

1321

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.3

27.1

2782

23459

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

26.8

3080

26394

SPAT1312

SPAT

General health counselling

1.4

26.7

1713

13415

B07.9

ICD-10 Finland

Verruca simplex

2.2

26.4

228

1062

G03HB01

ATC

cyproterone and estrogen; oral

1.6

26.3

619

3962

C07AA05

ATC

propranolol; systemic

1.4

26.1

1169

8592

R06.0

ICD-10 Finland

Dyspnoea

1.4

26.0

1423

10841

M01AH05

ATC

etoricoxib; oral

1.3

26.0

3642

32070

J05AB11

ATC

valaciclovir; oral

1.5

25.9

857

5928

R05

ICD-10 Finland

Cough

1.4

25.8

1225

9097

J01FA01

ATC

erythromycin; systemic

1.5

25.5

796

5436

D01AE16

ATC

amorolfine; topical

1.6

24.7

592

3804

L50.9

ICD-10 Finland

Urticaria, unspecified

2.1

24.7

247

1218

H15.1

ICD-10 Finland

Episcleritis

2.9

24.6

113

390

C01CA24

ATC

epinephrine; parenteral

1.8

24.4

387

2224

SPAT1310

SPAT

Counselling related to known health issue

1.4

24.3

1679

13267

QAA50

NOMESCO Finland

Cryotherapy of skin of head or neck

5.0

24.2

102

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

4.1

24.1

163

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.6

24.1

581

3738

J01FA06

ATC

roxithromycin; oral

1.3

23.8

2176

17930

S08

ICPC

Skin colour change

1.9

23.7

310

1677

N02AX02

ATC

tramadol; systemic, rectal

1.3

23.4

2262

18771

D07CC01

ATC

betamethasone and antibiotics; topical

1.6

23.4

668

4470

N02BE01

ATC

paracetamol; systemic, rectal

1.5

23.3

5243

49275

L20

ICD-10 Finland

Atopic dermatitis

2.2

23.2

206

970

L04AD01

ATC

ciclosporin; systemic

2.8

23.2

115

414

R01BA52

ATC

pseudoephedrine, combinations; oral

1.4

23.2

1686

13412

UJF30

NOMESCO Finland

Ileoscopy through colon

1.6

23.2

587

3820

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

3.2

23.1

282

T78.4

ICD-10 Finland

Allergy, unspecified

1.9

23.0

284

1508

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

1.8

23.0

355

2024

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.6

23.0

655

4380

L01XX05

ATC

hydroxycarbamide; oral

3.6

22.8

216

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.2

22.7

191

880

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

2.6

22.7

133

522

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

4.1

22.6

149

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

22.5

2221

18460

S01GX05

ATC

lodoxamide; ophthalmic

3.1

22.5

318

L43.8

ICD-10 Finland

Other lichen planus

2.8

22.2

114

418

L04AB04

ATC

adalimumab; parenteral

2.4

22.1

148

618

R03BA08

ATC

ciclesonide; inhalant

1.6

22.1

508

3227

L04AA01

ATC

[U] ciclosporin

3.2

22.1

280

K30

ICD-10 Finland

Functional dyspepsia

1.5

22.0

665

4504

SPAT1263

SPAT

Sampling

1.3

21.9

2236

18650

F45.8

ICD-10 Finland

Other somatoform disorders

1.7

21.9

439

2695

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.5

21.7

671

4564

M03BX02

ATC

tizanidine; oral

1.3

21.7

3600

32042

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.8

21.7

333

1896

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

1.8

21.6

305

1692

R06AX26

ATC

fexofenadine; oral

1.7

21.5

417

2535

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.5

21.4

639

4313

A07EC02

ATC

mesalazine; oral, rectal

1.9

21.3

292

1604

L30.0

ICD-10 Finland

Nummular dermatitis

2.1

21.2

212

1045

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

21.0

2121

17634

G47.3

ICD-10 Finland

Sleep apnoea

1.4

21.0

1170

8896

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.7

21.0

449

2801

A07EA06

ATC

budesonide; oral, local oral

2.0

21.0

218

1091

6953A

ICD-9 Finland

Erythematous conditions, Rosacea[ROSACEA]

+∞

20.8

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.7

20.8

402

2443

L01

ICPC

Neck symptom/complaint

1.4

20.8

970

7153

D04.3

ICD-10 Finland

Carcinoma in situ: Skin of other and unspecified parts of face

2.8

20.7

104

377

C44.81

ICD-10 Finland

Overall basocellular carcinoma of the skin

6.0

20.7

E000003, ,

ATC

2.0

20.7

239

1242

L23.8

ICD-10 Finland

Allergic contact dermatitis due to other agents

4.1

20.6

138

D07AC14

ATC

methylprednisolone aceponate; topical

1.9

20.4

253

1345

SPAT1301

SPAT

No procedures

1.3

20.4

1575

12593

A98

ICPC

Health maint/preventive medicine

2.1

20.4

5869

56974

R53

ICD-10 Finland

Malaise and fatigue

1.4

20.4

1382

10839

H93.1

ICD-10 Finland

Tinnitus

1.7

20.4

383

2310

R51.80

ICD-10 Finland

Headache

1.4

20.3

915

6702

L23.9

ICD-10 Finland

Allergic contact dermatitis, unspecified cause

3.2

20.3

243

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.5

20.2

690

4790

D06AX01

ATC

fusidic acid; topical

1.6

20.0

477

3056

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

2.2

20.0

178

840

R01AD01

ATC

beclometasone; nasal

1.4

19.9

836

6042

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.7

19.9

422

2627

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.1

19.8

200

991

SPAT1260

SPAT

Consultation of another employee

1.4

19.8

883

6455

Z01.2

ICD-10 Finland

Dental examination

1.3

19.7

2723

23533

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.8

19.7

324

1883

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.6

19.5

512

3355

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

19.5

1444

11466

S06

ICPC

Rash localized

1.8

19.3

291

1647

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

19.3

1549

12440

J01FA09

ATC

clarithromycin; systemic

1.3

19.1

1730

14127

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.5

19.1

728

5162

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

3.2

19.1

237

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.5

19.1

579

3920

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

2.8

19.0

333

L40

ICD-10 Finland

Psoriasis

2.5

19.0

121

495

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.3

19.0

1439

11458

J01DA09

ATC

[U] cefadroxil

1.3

19.0

1408

11176

K50.9

ICD-10 Finland

Crohn disease, unspecified

2.8

18.9

340

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

2.3

18.8

143

633

A02BC04

ATC

rabeprazole; oral

1.6

18.8

492

3223

S01GX02

ATC

levocabastine; ophthalmic

1.7

18.7

329

1948

G01AA10

ATC

clindamycin; vaginal

1.4

18.6

898

6649

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

18.5

1405

11180

S01GX08

ATC

ketotifen; ophthalmic

1.8

18.5

281

1595

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

18.4

3930

35724

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.6

18.4

422

2678

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

3.2

18.4

227

I73.0

ICD-10 Finland

Raynaud syndrome

2.5

18.2

114

463

L70.1

ICD-10 Finland

Acne conglobata

21.8

18.1

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

18.0

707

5039

B35.1

ICD-10 Finland

Tinea unguium

1.7

18.0

360

2208

N03AX16

ATC

[U] pregabalin

1.4

17.9

1172

9116

127

Kela drug reimbursment

Transplant complication

2.9

17.8

295

N03AX12

ATC

[U] gabapentin; oral

1.4

17.8

827

6080

69530

ICD-8 Finland

Erythematous condition, Rosacea

+∞

17.7

D06BX02

ATC

ingenol mebutate; topical

3.2

17.7

212

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

1.7

17.7

360

2217

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

17.7

4209

38680

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.7

17.6

364

2250

M54.5

ICD-10 Finland

Low back pain

1.3

17.6

2072

17471

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.3

17.6

1644

13455

Z94.0

ICD-10 Finland

Kidney transplant status

3.4

17.4

189

L01BA01

ATC

methotrexate; systemic

2.0

17.4

199

1030

UKC02

NOMESCO Finland

Cystoscopy

1.5

17.4

657

4647

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

17.3

2270

19386

N06AX11

ATC

mirtazapine; oral

1.3

17.3

1846

15365

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.7

17.3

355

2191

M54.6

ICD-10 Finland

Pain in thoracic spine

1.6

17.2

425

2745

L20.8

ICD-10 Finland

Other atopic dermatitis

2.9

17.1

285

M01AE02

ATC

naproxen; oral, rectal

1.3

17.1

3183

28332

A01AB09

ATC

miconazole; local oral

1.6

17.0

417

2688

D01BA02

ATC

terbinafine; oral

1.3

16.8

1229

9707

R60.0

ICD-10 Finland

Localized oedema

1.5

16.8

621

4372

H16.9

ICD-10 Finland

Keratitis, unspecified

2.5

16.7

104

421

SPAT1325

SPAT

Vaccination

1.3

16.7

1589

13018

M54.4

ICD-10 Finland

Lumbago with sciatica

1.4

16.7

1008

7735

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

2.0

16.7

170

846

R96

ICPC

Asthma

1.5

16.6

537

3680

D10AD01

ATC

tretinoin; topical

2.3

16.6

124

545

S01

ICPC

Pain/tenderness of skin

1.8

16.6

255

1452

H16.0

ICD-10 Finland

Corneal ulcer

1.8

16.6

264

1519

WZC00

NOMESCO Finland

Treatment plan or consultation

1.3

16.6

2032

17188

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.4

16.6

674

4834

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.3

16.5

1513

12328

XG474

NOMESCO Finland

Exhalation nntrogen oxide

2.1

16.5

148

701

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.5

16.4

496

3352

D05AX02

ATC

calcipotriol; topical

2.0

16.4

177

899

M79.1

ICD-10 Finland

Myalgia

1.4

16.4

844

6311

L40.5

ICD-10 Finland

Arthropathic psoriasis

2.5

16.3

104

426

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.4

16.3

979

7506

D45

ICD-10 Finland

Polycythaemia vera

3.5

16.2

154

G44.2

ICD-10 Finland

Tension-type headache

1.4

16.2

790

5852

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.6

16.2

439

2898

A02BA02

ATC

ranitidine; systemic

1.4

16.2

885

6683

L50.8

ICD-10 Finland

Other urticaria

2.3

16.1

116

502

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

1.9

16.1

201

1073

D22.5

ICD-10 Finland

Melanocytic naevi of trunk

1.6

16.0

348

2180

L13

ICPC

Hip symptom/complaint

1.4

15.9

1020

7893

M01AC06

ATC

meloxicam; systemic, rectal

1.3

15.9

1900

16001

R01AD11

ATC

triamcinolone; nasal

1.5

15.9

454

3031

ZY010

NOMESCO Finland

Hospital outpatient

1.7

15.8

276

1631

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.8

15.8

235

1326

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

1.7

15.7

327

2025

M13.9

ICD-10 Finland

Arthritis, unspecified

1.6

15.7

391

2530

N06AX21

ATC

duloxetine; oral

1.4

15.7

663

4787

L17

ICPC

Foot/toe symptom/complaint

1.3

15.7

1643

13610

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.5

15.6

506

3469

F03

ICPC

Eye discharge

1.6

15.6

380

2448

L04AD02

ATC

tacrolimus; systemic

3.2

15.5

188

ZXC10

NOMESCO Finland

Use of laser

2.3

15.5

114

498

R42

ICD-10 Finland

Dizziness and giddiness

1.3

15.5

1156

9145

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.7

15.5

299

1816

J45.9

ICD-10 Finland

Asthma, unspecified

1.3

15.4

997

7722

A07EC01

ATC

sulfasalazine; oral, rectal

1.6

15.4

402

2629

A01AB04

ATC

amphotericin B; local oral

1.9

15.4

206

1126

J45.1

ICD-10 Finland

Nonallergic asthma

1.6

15.4

357

2273

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.6

15.3

401

2624

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.4

15.3

805

6037

QCA25

NOMESCO Finland

Destruction of lesion of skin of upper limb

4.3

15.2

L08

ICPC

Shoulder symptom/complaint

1.3

15.2

1231

9851

Z00.0

ICD-10 Finland

General medical examination

1.4

15.2

964

7447

K51.5

ICD-10 Finland

Left sided colitis

2.1

15.1

145

706

H10.1

ICD-10 Finland

Acute atopic conjunctivitis

2.0

15.1

159

801

D04.4

ICD-10 Finland

Carcinoma in situ: Skin of scalp and neck

3.9

15.1

110

ZYC06

NOMESCO Finland

Real-time text-based remote transaction

5.6

15.1

J35.0

ICD-10 Finland

Chronic tonsillitis

1.7

15.0

297

1815

L53.9

ICD-10 Finland

Erythematous condition, unspecified

2.8

15.0

278

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.5

15.0

418

2775

P01AB01

ATC

metronidazole; oral, rectal

1.3

15.0

2242

19353

N05CF02

ATC

zolpidem; oral

1.4

15.0

926

7122

J01EA01

ATC

trimethoprim; systemic

1.3

14.8

1393

11362

L68.0

ICD-10 Finland

Hirsutism

6.8

14.8

M48.0

ICD-10 Finland

Spinal stenosis

1.5

14.8

536

3759

L30

ICD-10 Finland

Other dermatitis

2.1

14.8

139

672

L88

ICPC

Rheumatoid/seropositive arthritis

1.8

14.7

224

1273

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.4

14.7

737

5479

QCE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in upper limb

2.1

14.7

132

627

Z01.9

ICD-10 Finland

Special examination, unspecified

1.6

14.6

310

1929

SPAT1058

SPAT

PEF monitoring instruction

1.6

14.6

395

2607

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.5

14.5

501

3478

D07XB05

ATC

dexamethasone; topical

2.1

14.5

134

643

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.3

14.5

926

7154

M77.4

ICD-10 Finland

Metatarsalgia

1.6

14.4

352

2269

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.7

14.3

295

1822

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.5

14.3

491

3404

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.3

14.3

1979

16908

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

2.1

14.3

128

608

N76.1

ICD-10 Finland

Subacute and chronic vaginitis

2.0

14.2

163

846

R60.9

ICD-10 Finland

Oedema, unspecified

1.7

14.2

282

1725

L03

ICPC

Low back symptom/complaint

1.3

14.2

1627

13592

M79.0

ICD-10 Finland

Rheumatism, unspecified

1.9

14.2

190

1038

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

2.2

14.2

121

563

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.3

14.2

1330

10838

R03BA02

ATC

budesonide; inhalant

1.3

14.2

944

7337

K51.8

ICD-10 Finland

Other ulcerative colitis

2.5

14.1

346

R01AD05

ATC

budesonide; nasal

1.5

14.1

392

2603

F02

ICPC

Red eye

1.7

13.9

232

1354

R20.2

ICD-10 Finland

Paraesthesia of skin

1.5

13.9

391

2600

UDC00

NOMESCO Finland

Ear microscopy

1.6

13.9

358

2336

N77.1*B37.3

ICD-10 Finland

Candidiasis of vulva and vagina

2.0

13.8

143

716

K50.8

ICD-10 Finland

Other Crohn disease

2.5

13.8

355

L66.1

ICD-10 Finland

Lichen planopilaris

53.5

13.8

A03FA02

ATC

cisapride; oral, rectal

1.6

13.8

327

2093

C09CA06

ATC

candesartan; oral

1.3

13.7

1248

10125

WZC00, ,

SPAT

1.4

13.7

790

6005

377

Kela drug reimbursment

Apremilast and dimethyl fumarate (psoriasis)

5.3

13.7

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

1.8

13.6

195

1089

L63.8

ICD-10 Finland

Other alopecia areata

14.7

13.5

J01CA04

ATC

amoxicillin; systemic

1.3

13.5

4722

44516

A07AA02

ATC

nystatin; oral

1.7

13.4

268

1643

D86.3

ICD-10 Finland

Sarcoidosis of skin

5.6

13.3

QDA25

NOMESCO Finland

Destruction of lesion of skin of lower limb

4.3

13.3

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.2

13.3

2890

25851

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

13.3

1798

15289

M70.6

ICD-10 Finland

Trochanteric bursitis

1.4

13.3

725

5459

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.4

13.3

666

4948

QAE99

NOMESCO Finland

Other excision or repair surgery of skin and subcutaneous tissue in head and neck

2.4

13.2

387

9950/3-C42.1

ICD-O-3

Polycythemia vera of bone marrow

5.3

13.2

N02AJ06

ATC

codeine and paracetamol; systemic

1.2

13.2

2325

20347

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

2.2

13.2

105

476

L85.3

ICD-10 Finland

Xerosis cutis

2.8

13.1

241

G03DB01

ATC

dydrogesterone; oral

1.4

13.1

752

5712

K07.60

ICD-10 Finland

Snapping jaw

1.6

13.1

304

1937

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

2.0

13.0

147

760

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

13.0

2019

17425

R52.9

ICD-10 Finland

Pain, unspecified

1.4

13.0

535

3842

SDA03

NOMESCO Finland

Periodontal treatment

1.2

13.0

2299

20122

C03DA01

ATC

spironolactone; oral

1.4

12.9

502

3564

395

Kela drug reimbursment

Dupilumab

5.2

12.9

326

Kela drug reimbursment

Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)

2.8

12.9

232

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.2

12.9

2863

25638

R05

ICPC

Cough

1.3

12.9

1353

11166

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.3

12.9

949

7478

M03AX01

ATC

botulinum toxin; parenteral

2.3

12.8

399

H03AA01

ATC

levothyroxine sodium; systemic

1.3

12.8

1250

10221

H13

ICPC

Plugged feeling ear

1.3

12.8

901

7055

R03BA01

ATC

beclometasone; inhalant

1.4

12.7

691

5200

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.5

12.7

465

3266

L02.0

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of face

2.4

12.6

346

N76.0

ICD-10 Finland

Acute vaginitis

1.5

12.6

404

2762

C44.39

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology

4.4

12.6

L43.9

ICD-10 Finland

Lichen planus, unspecified

2.2

12.6

107

498

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.4

12.6

533

3846

L01.0

ICD-10 Finland

Impetigo [any organism] [any site]

2.3

12.6

415

C44.42

ICD-10 Finland

Spinocellular carcinoma of the skin of the scalp and neck

5.5

12.6

D06BB03

ATC

aciclovir; topical

1.7

12.6

244

1486

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

2.1

12.5

121

592

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.7

12.5

230

1381

D07AB01

ATC

clobetasone; topical

1.9

12.4

160

865

E000008, ,

ATC

5.6

12.4

J45

ICD-10 Finland

Asthma

1.4

12.4

555

4044

F01

ICPC

Eye pain

1.9

12.3

161

874

XX9XE

NOMESCO Finland

Other ultrasound examination

2.8

12.3

210

N39.3

ICD-10 Finland

Stress incontinence

1.5

12.3

406

2793

L01BC02

ATC

fluorouracil; systemic, topical

3.6

12.3

108

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

1.8

12.3

167

919

L23.5

ICD-10 Finland

Allergic contact dermatitis due to other chemical products

2.9

12.3

189

L30.4

ICD-10 Finland

Erythema intertrigo

2.4

12.2

339

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.5

12.2

425

2956

319

Kela drug reimbursment

Adalimumab, brodalumab, certolizumab pegol, etanercept, guselkumab, infliximab, ixekizumab, risankizumab, sekukinumab and ustekinumab (skin psoriasis)

3.7

12.2

104

L60.0

ICD-10 Finland

Ingrowing nail

1.7

12.2

210

1239

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.7

12.2

203

1187

F51.0

ICD-10 Finland

Nonorganic insomnia

1.3

12.1

964

7670

L29.2

ICD-10 Finland

Pruritus vulvae

2.1

12.0

110

527

R51

ICD-10 Finland

Headache

1.6

12.0

314

2058

SCA02

NOMESCO Finland

Preventive oral health care

1.4

11.9

515

3727

S01BA01

ATC

dexamethasone; ophthalmic

1.8

11.9

166

920

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.3

11.9

841

6581

L04AB01

ATC

etanercept; parenteral

2.2

11.9

425

S87

ICPC

Dermatitis/atopic eczema

2.0

11.9

131

673

N95.1

ICD-10 Finland

Menopausal and female climacteric states

1.3

11.9

827

6460

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.4

11.8

463

3293

L43.3

ICD-10 Finland

Subacute (active) lichen planus

5.4

11.8

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.4

11.8

663

5017

H00

ICD-10 Finland

Hordeolum and chalazion

2.6

11.7

250

DHB00

NOMESCO Finland

Excision of lesion of external nose

3.1

11.6

152

D11AH05

ATC

dupilumab; topical

4.7

11.6

SBB10

NOMESCO Finland

Dental impressions

1.5

11.6

338

2266

K50.0

ICD-10 Finland

Crohn disease of small intestine

2.3

11.6

366

SDA01

NOMESCO Finland

Periodontal treatment, very brief

1.2

11.6

1520

12845

D05AX03

ATC

calcitriol; topical

2.5

11.6

269

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.2

11.6

2298

20273

S01AD03

ATC

aciclovir; ophthalmic

1.8

11.6

171

965

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.3

11.6

984

7894

J34.2

ICD-10 Finland

Deviated nasal septum

1.6

11.4

238

1476

G01AF05

ATC

econazole; vaginal

1.4

11.4

448

3187

C05AA08

ATC

fluocortolone; rectal, topical

1.4

11.4

642

4859

M02AA07

ATC

piroxicam; topical

1.2

11.3

1720

14763

Z71.8

ICD-10 Finland

Other specified counselling

1.2

11.3

1861

16110

L50.0

ICD-10 Finland

Allergic urticaria

1.9

11.2

143

771

S04

ICPC

Lump/swelling localized

1.4

11.2

563

4181

D22.9

ICD-10 Finland

Melanocytic naevi, unspecified

1.6

11.2

282

1831

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.2

11.2

1609

13724

M01AH01

ATC

celecoxib; oral

1.3

11.2

858

6789

L15

ICPC

Knee symptom/complaint

1.3

11.2

1321

11029

L90.5

ICD-10 Finland

Scar conditions and fibrosis of skin

2.6

11.1

251

A07EA02

ATC

hydrocortisone; rectal

2.1

11.1

106

517

D07BC01

ATC

betamethasone and antiseptics; topical

1.4

11.1

548

4059

L84

ICD-10 Finland

Corns and callosities

1.8

11.1

159

890

L56.4

ICD-10 Finland

Polymorphous light eruption

3.6

11.0

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

1.8

11.0

149

819

Z3231

NOMESCO Finland

Registered nurse

1.3

11.0

1278

10644

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.5

11.0

404

2839

J01MA14

ATC

moxifloxacin; systemic

1.5

11.0

409

2881

SHA04

NOMESCO Finland

Stomatognathic treatment, very demanding

2.4

11.0

325

L40.8

ICD-10 Finland

Other psoriasis

3.1

11.0

147

EB4VA, ,

NOMESCO Finland

1.3

11.0

977

7881

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

11.0

179

1041

K50.1

ICD-10 Finland

Crohn disease of large intestine

2.5

11.0

253

R03BA05

ATC

fluticasone; inhalant

1.3

10.9

912

7295

TCC40

NOMESCO Finland

Closure of lacrimal canaliculus with plug

4.6

10.9

M01AH02

ATC

rofecoxib; oral

1.4

10.9

548

4070

C10AC01

ATC

colestyramine; oral

1.9

10.9

139

750

K03.64

ICD-10 Finland

Dental calculus supragingival

1.2

10.9

1815

15714

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.6

10.9

286

1876

L29.9

ICD-10 Finland

Pruritus, unspecified

1.8

10.9

149

823

H53.1

ICD-10 Finland

Subjective visual disturbances

1.5

10.8

361

2489

S01GX09

ATC

olopatadine; ophthalmic

1.8

10.8

155

867

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.5

10.8

362

2499

R06AX18

ATC

acrivastine; oral

1.9

10.8

141

767

TDM10

NOMESCO Finland

Puncture of maxillary antrum

1.7

10.8

192

1144

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.4

10.8

579

4347

R04.0

ICD-10 Finland

Epistaxis

1.5

10.8

308

2058

N02BF01

ATC

gabapentin; oral

1.4

10.8

531

3932

SAB01

NOMESCO Finland

Restricted oral and dental health check by dental hygienist or dental assistant

1.5

10.7

391

2743

XQ841

NOMESCO Finland

Examination of dermatosis with microscope

5.6

10.7

T78.3

ICD-10 Finland

Angioneurotic oedema

2.4

10.7

317

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.3

10.7

669

5143

ZYC01

NOMESCO Finland

Remote contact by phone

1.5

10.7

303

2022

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.3

10.7

690

5329

D09AB01

ATC

zinc bandage without supplements; topical

2.2

10.7

419

H10

ICD-10 Finland

Conjunctivitis

1.4

10.6

396

2790

M50.3

ICD-10 Finland

Other cervical disc degeneration

1.9

10.6

121

629

R03AC13

ATC

formoterol; inhalant

1.6

10.6

233

1465

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

3.6

10.6

M04AA01

ATC

allopurinol; systemic

1.4

10.6

457

3307

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.4

10.6

493

3615

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

1.7

10.6

189

1127

L64.9

ICD-10 Finland

Androgenic alopecia, unspecified

8.0

10.6

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

1.8

10.6

154

867

R03AC03

ATC

terbutaline; inhalant

1.3

10.5

693

5364

SCA01

NOMESCO Finland

Preventive oral health care, short

1.2

10.5

1529

13044

QXA50

NOMESCO Finland

Skin cryotherapy, unspecified location

3.3

10.5

120

L72.0

ICD-10 Finland

Epidermal cyst

2.8

10.5

173

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.4

10.4

416

2968

K58

ICD-10 Finland

Irritable bowel syndrome

1.8

10.4

144

798

R03AK08

ATC

formoterol and beclometasone; inhalant

1.6

10.4

234

1481

L63.9

ICD-10 Finland

Alopecia areata, unspecified

4.1

10.4

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

3.4

10.4

106

D82

ICPC

Teeth/gum disease

1.2

10.3

2070

18224

SFA20

NOMESCO Finland

Two-surface restoration

1.2

10.3

3292

30239

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

1.7

10.3

189

1137

DLW99

NOMESCO Finland

Other plastic operations on nose

18.8

10.2

M07.3

ICD-10 Finland

Other psoriatic arthropathies

2.5

10.2

244

A63.0

ICD-10 Finland

Anogenital (venereal) warts

1.7

10.2

188

1131

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

3.0

10.2

143

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

1.6

10.2

247

1591

H02.3

ICD-10 Finland

Blepharochalasis

1.5

10.2

305

2060

K51.3

ICD-10 Finland

Ulcerative (chronic) rectosigmoiditis

2.1

10.1

441

S01KA02

ATC

hypromellose; ophthalmic

2.2

10.0

390

C07AB07

ATC

bisoprolol; oral

1.2

10.0

2211

19627

L23.1

ICD-10 Finland

Allergic contact dermatitis due to adhesives

3.8

10.0

L04AA32

ATC

apremilast; oral

4.6

10.0

M54.2

ICD-10 Finland

Cervicalgia

1.4

10.0

419

3019

L57

ICD-10 Finland

Skin changes due to chronic exposure to nonionizing radiation

4.0

9.9

K03.00

ICD-10 Finland

Approximal wear

1.4

9.9

403

2885

ZXA10

NOMESCO Finland

Bilateral

1.3

9.9

815

6501

TQW40, ,

SPAT

1.4

9.9

489

3620

R03AK07

ATC

formoterol and budesonide; inhalant

1.3

9.9

1120

9287

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.3

9.9

1018

8349

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.6

9.9

240

1546

L40.4

ICD-10 Finland

Guttate psoriasis

3.5

9.9

F72

ICPC

Blepharitis/stye/chalazion

1.9

9.9

124

667

R08

ICPC

Nose symptom/complaint other

1.7

9.9

177

1058

R22.0

ICD-10 Finland

Localized swelling, mass and lump, head

1.8

9.9

153

878

QXE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in uspecified region

3.1

9.9

125

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

2.1

9.8

413

M76.8

ICD-10 Finland

Other enthesopathies of lower limb, excluding foot

1.9

9.8

113

590

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.6

9.8

228

1454

D04.2

ICD-10 Finland

Carcinoma in situ: Skin of ear and external auricular canal

5.1

9.8

H57.1

ICD-10 Finland

Ocular pain

1.6

9.8

208

1298

R00.2

ICD-10 Finland

Palpitations

1.4

9.8

424

3071

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.6

9.8

224

1424

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.4

9.8

443

3234

R09

ICPC

Sinus symptom/complaint

1.4

9.7

458

3364

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.4

9.7

548

4144

R4110, ,

SPAT

1.3

9.7

674

5256

K60.2

ICD-10 Finland

Anal fissure, unspecified

2.1

9.6

443

R02

ICPC

Shortness of breath/dyspnoea

1.3

9.6

636

4925

M45

ICD-10 Finland

Ankylosing spondylitis

2.0

9.6

491

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.3

9.6

737

5826

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.4

9.6

450

3304

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.3

9.6

639

4954

H16.2

ICD-10 Finland

Keratoconjunctivitis

2.9

9.6

154

L04AC18

ATC

risankizumab; parenteral

5.0

9.6

F16

ICPC

Eyelid symptom/complaint

1.5

9.5

260

1721

I49.1

ICD-10 Finland

Atrial premature depolarization

1.7

9.5

182

1107

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.4

9.5

463

3422

ZXX02

NOMESCO Finland

Extent of procedure, 2 units

2.3

9.5

290

J30.0

ICD-10 Finland

Vasomotor rhinitis

1.8

9.5

133

741

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.1

9.4

400

L23

ICD-10 Finland

Allergic contact dermatitis

3.0

9.4

139

S96

ICPC

Acne

2.6

9.4

212

M43.1

ICD-10 Finland

Spondylolisthesis

1.6

9.4

192

1187

AA3AI

NOMESCO Finland

Cone beam CT of facial bones

2.5

9.4

242

SAD01

NOMESCO Finland

Assessment of need for oral health care, standard

1.3

9.4

712

5618

QAA30

NOMESCO Finland

Electrocoagulation of skin of head or neck

30.1

9.4

380

Kela drug reimbursment

Adalimumab (hidradenitis suppurativa)

+∞

9.4

D01AC02

ATC

miconazole; topical

1.5

9.4

304

2087

M79.7

ICD-10 Finland

Fibromyalgia

1.6

9.3

201

1261

D47.1

ICD-10 Finland

Chronic myeloproliferative disease

4.5

9.3

R05FB02

ATC

cough suppressants and expectorants; systemic

1.2

9.3

1790

15666

130

Kela drug reimbursment

Malignant tumour

0.6

9.3

144

2421

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

1.9

9.3

107

560

H25.1

ICD-10 Finland

Senile nuclear cataract

1.3

9.3

1026

8484

L65.8

ICD-10 Finland

Other specified nonscarring hair loss

9.5

9.2

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.4

9.2

432

3171

G50.1

ICD-10 Finland

Atypical facial pain

2.0

9.2

492

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

2.3

9.2

307

A11CC03

ATC

alfacalcidol; systemic

2.0

9.2

486

H16.8

ICD-10 Finland

Other keratitis

4.2

9.2

L04AC05

ATC

ustekinumab; parenteral

3.4

9.2

R74

ICPC

Upper respiratory infection acute

1.2

9.1

1865

16403

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.4

9.1

493

3705

-1, ,

NOMESCO Finland

1.2

9.1

1704

14870

C03CA01

ATC

furosemide; systemic

1.2

9.1

1129

9455

QDE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in lower limb

1.8

9.0

138

789

L53.8

ICD-10 Finland

Other specified erythematous conditions

4.0

9.0

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.4

9.0

403

2935

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.2

9.0

3034

27849

N05CF01

ATC

zopiclone; oral

1.2

9.0

1509

13025

L28.1

ICD-10 Finland

Prurigo nodularis

2.9

9.0

143

D01AA02

ATC

natamycin; topical

2.0

9.0

483

R50.9

ICD-10 Finland

Fever, unspecified

1.3

8.9

697

5519

ZX120

NOMESCO Finland

Intravenous

1.4

8.9

405

2957

CBB30

NOMESCO Finland

Excision of lesion of eyelid

1.8

8.9

127

711

M03BC01

ATC

orphenadrine (citrate); systemic

1.2

8.9

1165

9807

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.5

8.9

271

1837

B35.3

ICD-10 Finland

Tinea pedis

1.6

8.9

219

1418

J01DC02

ATC

cefuroxime; systemic

1.5

8.9

265

1789

WYA10

NOMESCO Finland

Emergency care or similar visit

1.4

8.9

358

2562

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.3

8.9

526

4009

QXA05

NOMESCO Finland

Skin division, unspecified location

3.9

8.9

WZC30

NOMESCO Finland

Teaching

1.3

8.8

782

6293

WZA90

NOMESCO Finland

Other medical or dental certificate

1.2

8.8

1172

9879

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

1.8

8.8

119

656

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.2

8.8

1216

10294

G03DC02

ATC

norethisterone; oral

1.3

8.8

540

4139

R07.0

ICD-10 Finland

Pain in throat

1.4

8.8

377

2729

C05AA01

ATC

hydrocortisone; rectal, topical

1.6

8.7

220

1432

R13

ICD-10 Finland

Dysphagia

1.4

8.7

315

2209

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.6

8.7

209

1345

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.4

8.7

484

3654

R19.4

ICD-10 Finland

Change in bowel habit

1.7

8.7

146

859

J01FA15

ATC

telithromycin; oral

1.4

8.6

477

3596

GD1AA, ,

SPAT

1.3

8.6

859

7011

L85.81

ICD-10 Finland

Keratosis pilaris

6.6

8.6

D06BB04

ATC

podophyllotoxin; topical

1.5

8.6

243

1622

M34.1

ICD-10 Finland

CR(E)ST syndrome

3.3

8.6

D22.7

ICD-10 Finland

Melanocytic naevi of lower limb, including hip

1.9

8.6

101

533

N30.0

ICD-10 Finland

Acute cystitis

1.3

8.6

911

7493

XQ801

NOMESCO Finland

Intracutantest

2.9

8.6

136

ZQX00

NOMESCO Finland

0-4% of the skin

8.2

8.6

J30.3

ICD-10 Finland

Other allergic rhinitis

1.6

8.5

182

1139

J46

ICD-10 Finland

Status asthmaticus

1.7

8.5

140

818

R21

ICPC

Throat symptom/complaint

1.2

8.5

1148

9689

J30.4

ICD-10 Finland

Allergic rhinitis, unspecified

1.6

8.5

200

1282

R12

ICD-10 Finland

Heartburn

1.4

8.5

419

3104

M01CB01

ATC

sodium aurothiomalate; parenteral

2.3

8.5

273

N05BA01

ATC

diazepam; systemic, rectal

1.3

8.5

563

4362

-, ,

ICD-10 Finland

2.0

8.4

480

S01GX04

ATC

nedocromil; ophthalmic

2.0

8.4

425

ZQZ00

NOMESCO Finland

Treatment of several skin areas

3.7

8.4

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.4

8.4

460

3463

D04.5

ICD-10 Finland

Carcinoma in situ: Skin of trunk

2.9

8.4

132

L40.9

ICD-10 Finland

Psoriasis, unspecified

2.1

8.4

359

R30.0

ICD-10 Finland

Dysuria

1.6

8.3

212

1383

U02

ICPC

Urinary frequency/urgency

1.3

8.3

760

6139

NA3BG, ,

SPAT

1.5

8.3

216

1416

S82

ICPC

Naevus/mole

1.3

8.3

719

5769

HMAK, ,

NOMESCO Finland

1.3

8.3

562

4365

H19.3*M35.0

ICD-10 Finland

Keratoconjunctivitis sicca

3.5

8.2

D02

ICPC

Abdominal pain epigastric

1.4

8.2

316

2242

R49.01

ICD-10 Finland

Functional dysphonia

1.7

8.2

151

910

N04BC05

ATC

pramipexole; oral

1.4

8.2

335

2402

XG410

NOMESCO Finland

Flow-volume spirometry

1.7

8.2

160

979

L01.1

ICD-10 Finland

Impetiginization of other dermatoses

3.1

8.2

102

ZZR00

NOMESCO Finland

Flap of skin

2.0

8.2

409

M02AA10

ATC

ketoprofen; topical

1.3

8.2

745

6015

3042, ,

Kela drug reimbursment

4.2

8.2

F13

ICPC

Eye sensation abnormal

1.7

8.2

137

806

AA1AD

NOMESCO Finland

CT of head and brain

1.2

8.1

1266

10835

N95.2

ICD-10 Finland

Postmenopausal atrophic vaginitis

1.4

8.1

453

3420

SCA03

NOMESCO Finland

Preventive oral health care, extensive

1.5

8.1

227

1512

K07.65

ICD-10 Finland

Temporomandibular joint-pain-dysfunction syndrome

2.3

8.1

253

KMAK, ,

NOMESCO Finland

1.2

8.1

2768

25352

SFA10

NOMESCO Finland

One-surface restoration

1.2

8.1

3026

27910

J45.8

ICD-10 Finland

Mixed asthma

1.7

8.1

141

839

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.4

8.0

445

3359

G54.0

ICD-10 Finland

Brachial plexus disorders

1.7

8.0

135

796

253, ,

Kela drug reimbursment

4.1

8.0

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

1.6

8.0

164

1018

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

1.6

8.0

174

1096

L50

ICD-10 Finland

Urticaria

1.9

8.0

518

K13.74

ICD-10 Finland

Lichen rubs planus in the mouth

2.0

8.0

441

N06AA09

ATC

amitriptyline; systemic

1.4

8.0

422

3162

H92.0

ICD-10 Finland

Otalgia

1.4

8.0

329

2366

L81.7

ICD-10 Finland

Pigmented purpuric dermatosis

3.5

8.0

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.5

7.9

278

1940

XKD00

NOMESCO Finland

Uroflowmetry

1.3

7.9

497

3821

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

7.9

2491

22663

I78.8

ICD-10 Finland

Other diseases of capillaries

6.1

7.8

D23.9

ICD-10 Finland

Benign neoplasm: Skin, unspecified

1.8

7.8

121

696

TPH04

NOMESCO Finland

Cathetrisation of vein

1.2

7.8

1008

8462

SDA04

NOMESCO Finland

Demanding periodontal treatment

1.2

7.8

1549

13552

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.4

7.8

286

2012

J02AB02

ATC

ketoconazole; oral

1.7

7.8

133

787

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.4

7.8

406

3036

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.2

7.7

1000

8396

JG1JB

NOMESCO Finland

Defekography with X-ray

2.5

7.7

191

L57.3

ICD-10 Finland

Poikiloderma of Civatte

15.0

7.7

C08CA13

ATC

lercanidipine; oral

1.3

7.7

603

4777

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

1.6

7.7

176

1122

D18.0

ICD-10 Finland

Haemangioma, any site

1.7

7.7

123

715

H20.1

ICD-10 Finland

Chronic iridocyclitis

2.4

7.7

222

L01BB02

ATC

mercaptopurine; oral

2.2

7.7

279

J01CA08

ATC

pivmecillinam; oral

1.2

7.7

2350

21312

J01CF05

ATC

flucloxacillin; systemic

1.4

7.6

320

2308

H02.1

ICD-10 Finland

Ectropion of eyelid

2.9

7.6

123

S02

ICPC

Pruritus

1.6

7.6

166

1046

H29

ICPC

Ear symptom/complaint other

1.3

7.6

570

4489

L01

ICD-10 Finland

Impetigo

2.0

7.6

366

KA9AE

NOMESCO Finland

Ultrasound examination transplanted kidney

4.0

7.6

L43

ICD-10 Finland

Lichen planus

2.2

7.6

293

R03AC12

ATC

salmeterol; inhalant

1.6

7.6

174

1110

H02AB09

ATC

hydrocortisone; systemic

1.8

7.6

112

636

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.5

7.6

220

1479

H01.1

ICD-10 Finland

Noninfectious dermatoses of eyelid

2.9

7.6

118

G03FA17

ATC

drospirenone and estrogen; systemic

1.7

7.6

118

681

KA1AE

NOMESCO Finland

Kidney ultrasound examination

1.8

7.5

103

571

XQ899

NOMESCO Finland

Other assessment of skin

3.1

7.5

UJF92

NOMESCO Finland

Capsular endoscopy

1.8

7.5

101

557

J34.8

ICD-10 Finland

Other specified disorders of nose and nasal sinuses

2.2

7.5

262

WXQ12

NOMESCO Finland

Psoralen - Ultraviolet A therapy with local sensitivisation

3.4

7.5

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.3

7.5

547

4293

D22

ICD-10 Finland

Melanocytic naevi

1.4

7.5

282

1996

D01AE15

ATC

terbinafine; topical

1.4

7.5

282

1996

SBA00

NOMESCO Finland

Microbiological examinations

1.7

7.5

119

691

D11AX15

ATC

[U] pimecrolimus

4.2

7.5

A12AA04

ATC

calcium carbonate; oral

2.2

7.4

276

R07.3

ICD-10 Finland

Other chest pain

1.3

7.4

475

3660

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.4

7.4

346

2540

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.3

7.4

479

3696

K59.0

ICD-10 Finland

Constipation

1.5

7.4

239

1641

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.3

7.4

499

3873

R05FA02

ATC

opium derivatives and expectorants; systemic

1.2

7.4

1986

17806

H01

ICPC

Ear pain/earache

1.3

7.4

604

4812

L64.8

ICD-10 Finland

Other androgenic alopecia

13.4

7.4

QA4S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in face

3.2

7.4

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

2.2

7.4

258

H10.2

ICD-10 Finland

Other acute conjunctivitis

2.0

7.3

371

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.5

7.3

253

1761

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

1.5

7.3

197

1303

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.4

7.3

343

2521

R83

ICPC

Respiratory infection other

1.2

7.3

1388

12088

M35.1

ICD-10 Finland

Other overlap syndromes

3.0

7.3

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

1.9

7.3

491

R01AD59

ATC

mometasone, combinations; nasal

1.4

7.3

355

2626

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

1.6

7.3

159

1003

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.4

7.3

275

1947

TEA00

NOMESCO Finland

Biopsy of lip

2.3

7.3

215

LEG10

NOMESCO Finland

Vaginal urethrocystopexy

1.7

7.3

114

659

A06AD11

ATC

lactulose; oral

1.3

7.3

556

4391

TGC00

NOMESCO Finland

Bronchial lavation

1.8

7.3

542

WX110

NOMESCO Finland

Infiltration anesthesia

1.2

7.3

4022

38085

L94.0

ICD-10 Finland

Localized scleroderma [morphea]

3.2

7.2

G03CA04

ATC

estriol; systemic, vaginal

1.5

7.2

228

1559

H04.5

ICD-10 Finland

Stenosis and insufficiency of lacrimal passages

1.8

7.2

102

572

D01

ICPC

Abdominal pain/cramps general

1.3

7.2

626

5024

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

2.0

7.2

374

DFF00

NOMESCO Finland

Pure tone audiometry

1.3

7.2

443

3397

C44.10

ICD-10 Finland

Malignant tumor of the skin of the eyelids including the corner of the eye without histology

3.7

7.2

L01XX35

ATC

anagrelide; oral

7.3

7.2

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

1.9

7.2

423

G04CA02

ATC

tamsulosin; oral

1.3

7.1

684

5554

JHB00

NOMESCO Finland

Hemorrhoidectomy

1.6

7.1

149

930

K02.0

ICD-10 Finland

Caries limited to enamel

1.2

7.1

1048

8909

L04AA13

ATC

[U] leflunomide

1.7

7.1

118

693

NH3EA

NOMESCO Finland

Feet X-ray examination with load

1.8

7.1

524

R5140

NOMESCO Finland

Monitoring the use of the aid

1.3

7.1

466

3605

G03FB08

ATC

dydrogesterone and estrogen; systemic

1.4

7.1

317

2312

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

1.6

7.1

156

987

ZXC20

NOMESCO Finland

Use of chemical agents

2.0

7.1

349

A05

ICPC

Feeling ill

1.4

7.0

285

2044

G04CB01

ATC

finasteride; oral

1.4

7.0

280

2002

L04AA17

ATC

[U] adalimumab

3.6

7.0

D01AC08

ATC

ketoconazole; topical

2.1

7.0

303

SPAT1216

SPAT

Assessment of functional ability

1.3

7.0

610

4898

C44.61

ICD-10 Finland

Basocellular carcinoma of the skin of the upper extremity including the shoulder

2.5

7.0

176

D94

ICPC

Chronic enteritis/ulcerative colitis

2.5

7.0

176

WX002

NOMESCO Finland

Sedation and analgesia

1.2

7.0

835

6951

S01AA02

ATC

chlortetracycline; ophthalmic

2.7

7.0

135

L02

ICPC

Back symptom/complaint

1.3

7.0

520

4094

L29.0

ICD-10 Finland

Pruritus ani

2.2

7.0

245

K13.00

ICD-10 Finland

Cheilitis NOS

2.6

6.9

141

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.5

6.9

230

1589

K08.80

ICD-10 Finland

Toothache NOS

1.3

6.9

467

3626

H02

ICPC

Hearing complaint

1.3

6.9

621

5003

L81.4

ICD-10 Finland

Other melanin hyperpigmentation

2.4

6.9

195

N95.0

ICD-10 Finland

Postmenopausal bleeding

1.3

6.9

420

3214

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.4

6.9

308

2246

H04.2

ICD-10 Finland

Epiphora

2.5

6.9

171

K06

ICPC

Prominent veins

5.4

6.9

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.4

6.9

305

2221

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.2

6.9

738

6070

M07.5*K51.9

ICD-10 Finland

Arthropathy in ulcerative colitis

3.6

6.9

X59

ICD-10 Finland

Exposure to unspecified factor

1.2

6.8

875

7333

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.3

6.8

388

2939

Z96.5

ICD-10 Finland

Presence of tooth-root and mandibular implants

3.4

6.8

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

1.6

6.8

148

933

C07AG02

ATC

carvedilol; oral

1.5

6.8

205

1390

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.2

6.8

1179

10176

P06

ICPC

Sleep disturbance

1.3

6.8

658

5351

R03BC03

ATC

nedocromil; inhalant

1.4

6.8

305

2228

A92

ICPC

Allergy/allergic reaction NOS

1.6

6.8

156

998

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.2

6.8

2227

20251

SAA04

NOMESCO Finland

Special examination of mouth

1.5

6.8

229

1590

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

1.9

6.7

425

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.5

6.7

206

1401

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

1.7

6.7

107

622

N07CA01

ATC

betahistine; oral

1.4

6.7

294

2137

G03FA14

ATC

dydrogesterone and estrogen; systemic

1.4

6.7

332

2463

B00.11

ICD-10 Finland

Herpes simplex labialis

1.8

6.7

512

A06AC51

ATC

ispaghula, combinations; oral

1.5

6.7

205

1395

R06.5

ICD-10 Finland

Mouth breathing

1.3

6.7

387

2941

QAE20

NOMESCO Finland

Excision and repair of scar or web of skin of head or neck

3.2

6.7

A46

ICD-10 Finland

Erysipelas

1.3

6.7

583

4682

L63.0

ICD-10 Finland

Alopecia (capitis) totalis

22.5

6.7

I49.4

ICD-10 Finland

Other and unspecified premature depolarization

1.6

6.7

166

1081

C02AC05

ATC

moxonidine; oral

1.5

6.7

170

1113

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.4

6.7

320

2363

K90.0

ICD-10 Finland

Coeliac disease

1.6

6.7

129

791

137

Kela drug reimbursment

Uraemia requiring dialysis

2.6

6.6

133

EKA10

NOMESCO Finland

iopsy of buccal mucosa

1.7

6.6

104

603

L23.3

ICD-10 Finland

Allergic contact dermatitis due to drugs in contact with skin

2.6

6.6

139

D23.3

ICD-10 Finland

Benign neoplasm: Skin of other and unspecified parts of face

1.7

6.6

113

671

J01XC01

ATC

fusidic acid; systemic

2.1

6.6

264

SPAT1324

SPAT

Screening procedure

1.2

6.6

1031

8814

R19.5

ICD-10 Finland

Other faecal abnormalities

1.9

6.6

443

SBB00

NOMESCO Finland

Clinical photography of mouth and teeth

1.6

6.6

154

989

XPX04

NOMESCO Finland

Angioscopy

3.1

6.6

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

1.6

6.6

151

966

M01AX01

ATC

nabumetone; oral

1.5

6.5

171

1126

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

1.6

6.5

133

826

C07AB02

ATC

metoprolol; systemic

1.2

6.5

763

6335

UJH02

NOMESCO Finland

Anoscopy

1.5

6.5

176

1167

J01MA06

ATC

norfloxacin; oral

1.3

6.5

593

4786

R22.1

ICD-10 Finland

Localized swelling, mass and lump, neck

1.5

6.5

189

1273

L12

ICPC

Hand/finger symptom/complaint

1.2

6.5

866

7288

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.3

6.5

517

4105

L18

ICPC

Muscle pain

1.5

6.5

192

1298

C10AX09

ATC

ezetimibe; oral

1.2

6.5

709

5845

D11AX14

ATC

[U] tacrolimus

2.8

6.5

112

H01.9

ICD-10 Finland

Inflammation of eyelid, unspecified

1.9

6.4

446

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

1.5

6.4

215

1489

N05BB01

ATC

hydroxyzine; systemic

1.4

6.4

262

1882

SPAT1141

SPAT

Excision of skin or mucous membrane lesion

1.5

6.4

183

1228

B35.8

ICD-10 Finland

Other dermatophytoses

3.3

6.4

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.2

6.4

819

6865

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.4

6.4

275

1995

L02.8

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of other sites

1.9

6.4

412

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

1.4

6.4

249

1777

L08.0

ICD-10 Finland

Pyoderma

2.3

6.3

197

C08CA01

ATC

amlodipine; oral

1.2

6.3

1657

14792

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

1.7

6.3

110

656

Z00.8

ICD-10 Finland

Other general examinations

1.3

6.3

352

2660

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.2

6.3

960

8180

Z49.1

ICD-10 Finland

Extracorporeal dialysis

2.2

6.3

229

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.4

6.3

284

2075

K11.2

ICD-10 Finland

Sialoadenitis

1.6

6.3

154

999

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

2.1

6.3

262

ZX108

NOMESCO Finland

Inhalation

2.6

6.3

125

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.4

6.3

256

1839

N64.4

ICD-10 Finland

Mastodynia

1.5

6.3

181

1217

L29.8

ICD-10 Finland

Other pruritus

2.0

6.3

323

D07XB02

ATC

triamcinolone; topical

2.0

6.3

303

H60.8

ICD-10 Finland

Other otitis externa

1.6

6.3

144

922

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

2.5

6.2

155

70610

ICD-8 Finland

Diseases of sebaceous glands, Acne vulgaris

+∞

6.2

70620

ICD-8 Finland

Diseases of sebaceous glands, Sebaceous cyst

+∞

6.2

D75.2

ICD-10 Finland

Essential thrombocytosis

2.7

6.2

120

L68.9

ICD-10 Finland

Hypertrichosis, unspecified

26.7

6.2

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.3

6.2

370

2825

B05DA

ATC

Isotonic solutions

2.8

6.2

109

G43.9

ICD-10 Finland

Migraine, unspecified

1.4

6.2

326

2444

S15

ICPC

Foreign body in skin

1.4

6.2

285

2093

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.5

6.1

171

1142

DHB10

NOMESCO Finland

Excision of lesion of internal nose

3.5

6.1

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.2

6.1

1530

13601

QBA50

NOMESCO Finland

Cryotherapy of skin of trunk

5.3

6.1

C44.21

ICD-10 Finland

Basocellular carcinoma of the skin of the outer ear and the outer ear canal

2.7

6.1

121

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

1.8

6.1

512

J01DA06

ATC

[U] cefuroxime

1.2

6.1

652

5357

XG480

NOMESCO Finland

Histamine provocation of respiratroy tract

1.9

6.1

368

K13.03

ICD-10 Finland

Keilit UNS

3.4

6.1

L01BC06

ATC

capecitabine; oral

0.5

6.1

1077

M19.9

ICD-10 Finland

Arthrosis, unspecified

1.5

6.1

188

1282

M23.8

ICD-10 Finland

Other internal derangements of knee

1.5

6.1

173

1160

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.3

6.1

589

4787

8070/3-C44.3

ICD-O-3

Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face

3.8

6.1

J20

ICD-10 Finland

Acute bronchitis

1.3

6.1

490

3898

H26.3

ICD-10 Finland

Drug-induced cataract

2.7

6.1

116

S91

ICPC

Psoriasis

2.2

6.1

201

K59.1

ICD-10 Finland

Functional diarrhoea

1.4

6.1

249

1793

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

1.6

6.1

138

882

L43.0

ICD-10 Finland

Hypertrophic lichen planus

2.8

6.0

105

L28

ICPC

Limited function/disability (L)

1.2

6.0

797

6699

D07CB01

ATC

triamcinolone and antibiotics; topical

1.8

6.0

456

S01AA13

ATC

fusidic acid; ophthalmic

1.6

6.0

124

773

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

1.6

6.0

141

907

X58

ICD-10 Finland

Exposure to other specified factors

1.2

6.0

678

5607

SPAT1053

SPAT

Memory test

1.3

6.0

452

3564

H02.9

ICD-10 Finland

Disorder of eyelid, unspecified

3.2

6.0

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3037522) Nuclear Ab [Titer] in Serum

1540

8419

2.11

126.32

1.6

1.4

599.14

538.96

titre

0.51

373

1821

(40768443) Skin Pathology biopsy report

633

2406

2.82

116.44

1.4

1.2

—

(3023420) DNA double strand Ab [Units/volume] in Serum

633

2487

2.73

109.00

2.4

1.9

13.74

7.21

iu/ml

0.45

178

588

(3015171) Extractable nuclear Ab [Units/volume] in Serum

593

2419

2.61

94.22

1.4

1.3

1.24

1.19

u/ml

0.03

201

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

4821

40376

1.97

93.86

5.9

4.4

11.28

11.49

mm/h

0.50

4581

38087

(3001604) Monocytes [#/volume] in Blood

3635

27999

1.75

92.82

8.6

6.3

0.54

0.56

e9/l

8.00

3271

24152

(3006315) Basophils [#/volume] in Blood

3640

28063

1.75

92.50

8.6

6.3

0.04

e9/l

0.25

3277

24191

(3013115) Eosinophils [#/volume] in Blood

3716

28962

1.74

89.33

8.8

6.5

0.18

0.19

e9/l

4.00

3384

25416

(3019198) Lymphocytes [#/volume] in Blood

3680

28655

1.73

88.22

8.6

6.4

1.89

1.93

e9/l

0.70

3363

25343

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

479

1832

2.75

86.26

2.4

1.8

1.17

1.19

g/l

0.93

462

1748

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

468

1774

2.78

85.73

2.4

1.9

0.22

0.23

g/l

0.99

447

1688

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

392

1410

2.90

79.07

1.4

1.3

7.63

2.67

u/ml

0.69

(3005322) IgE [Units/volume] in Serum or Plasma

793

3972

2.15

78.08

1.4

1.3

186.31

204.41

u/ml

0.25

755

3694

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

465

1842

2.65

77.96

1.4

1.3

32.61

40.20

u/ml

0.26

104

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

437

1702

2.69

75.73

1.4

1.3

10.69

7.61

u/ml

0.34

245

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

437

1702

2.69

75.73

1.5

1.3

10.72

5.02

u/ml

0.60

152

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

392

1477

2.77

72.39

1.4

1.3

11.28

19.45

u/ml

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

4780

41037

1.80

71.36

9.7

8.2

75.76

77.65

u/l

2.71

4567

39093

(3013650) Neutrophils [#/volume] in Blood by Automated count

3841

31342

1.62

66.91

10.9

9.7

3.89

4.02

e9/l

3.37

3489

27241

(3019069) Monocytes/Leukocytes in Blood

3261

25710

1.58

64.60

8.9

6.6

8.64

8.65

0.02

3102

24158

(3006504) Eosinophils/Leukocytes in Blood

3252

25670

1.58

63.70

8.8

6.5

2.82

2.83

0.08

3089

24085

(3018010) Neutrophils/Leukocytes in Blood

3275

25938

1.57

62.87

8.5

6.4

56.76

56.90

0.31

3158

24812

(3022096) Basophils/Leukocytes in Blood

3241

25669

1.57

61.73

8.9

6.6

0.74

0.69

5.10

3076

24060

(40760892) CBC W Ordered Manual Differential panel - Blood

1854

12920

1.63

60.93

6.1

4.5

—

(3002030) Lymphocytes/Leukocytes in Blood

3307

26416

1.56

59.84

8.8

6.5

28.74

28.47

0.77

3164

25062

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1669

11467

1.63

57.42

1.4

1.3

30.97

31.00

iu/ml

0.00

502

3523

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3224

25831

1.53

55.84

3.0

2.5

78.70

77.09

nmol/l

2.58

2997

23736

(3007853) Bacteria identified in Skin by Aerobe culture

1017

6205

1.77

54.19

1.9

1.7

—

(3048689) Calprotectin [Mass/mass] in Stool

1216

7838

1.69

53.04

3.1

2.4

115.40

123.15

ug/g

0.40

967

6241

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

240

821

3.00

52.78

1.3

1.2

29.14

10.54

u/ml

0.76

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

4925

43754

1.69

51.84

5.4

4.7

14.65

14.62

pmol/l

0.41

4612

40729

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

340

1407

2.50

51.71

1.4

1.3

42.79

43.67

u/ml

0.04

140

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1549

10687

1.60

51.37

1.4

1.3

8.61

10.55

u/ml

0.66

661

4331

(3029937) Albumin [Presence] in Urine by Test strip

2129

15820

1.53

50.81

5.0

4.0

0.00

estimate

2.60

739

5679

(3037467) Urinalysis macro (dipstick) panel - Urine

4294

37007

1.56

50.25

5.5

4.5

0.73

2.68

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1923

14046

1.54

49.30

1.4

1.3

1.38

1.58

u/ml

0.29

556

3951

(3021601) Nitrite [Presence] in Urine by Test strip

3503

29007

1.50

48.71

4.8

3.8

0.00

estimate

0.74

784

6041

(3009261) Glucose [Presence] in Urine by Test strip

3554

29516

1.50

48.71

4.8

3.8

0.01

0.07

estimate

0.63

750

5873

(3035350) Ketones [Presence] in Urine by Test strip

3525

29320

1.49

47.24

4.8

3.8

1.85

3.91

estimate

0.49

783

6179

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

5457

50327

1.89

45.26

6.6

5.6

1.83

1.85

mu/l

0.46

5157

47236

(3007164) IgA [Mass/volume] in Serum or Plasma

1676

12083

1.54

44.71

1.6

1.5

2.44

2.31

g/l

1.91

1105

7647

(3000494) Fungus identified in Specimen by Culture

1029

6621

1.67

44.31

1.6

1.5

—

(3015736) pH of Urine

2888

23275

1.46

44.23

4.2

3.4

6.26

6.22

1.42

1641

13203

(3026493) Urate [Moles/volume] in Serum or Plasma

1868

13821

1.51

43.95

3.1

2.5

329.95

326.86

umol/l

0.68

1648

12351

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

5646

52783

2.10

43.35

18.0

14.8

19.52

22.37

mg/l

9.59

4721

43202

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2748

22041

1.45

42.54

4.6

3.7

0.04

0.28

estimate

1.01

648

4986

(40768804) Tissue Pathology biopsy report

2831

22890

1.45

41.67

2.4

2.1

—

(3005719) IgG [Mass/volume] in Serum or Plasma

732

4385

1.76

40.69

3.4

2.9

10.69

10.56

g/l

0.36

681

4065

(3001122) Ferritin [Mass/volume] in Serum or Plasma

3363

28185

1.44

40.07

3.6

3.2

113.22

104.57

ug/l

0.81

3164

26562

(3024561) Albumin [Mass/volume] in Serum or Plasma

2889

23636

1.43

38.80

5.9

5.0

36.46

36.08

g/l

3.72

2719

22228

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

3335

28222

1.41

35.65

6.2

6.5

10.82

10.77

umol/l

0.10

3155

26908

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2174

17131

1.42

34.82

3.0

2.7

57.30

63.69

u/l

0.74

2003

15940

(3039162) Centromere protein B Ab [Units/volume] in Serum

196

756

2.65

34.43

1.4

1.3

74.58

65.20

u/ml

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

3145

26454

1.39

34.19

8.0

7.0

1.22

mmol/l

0.41

2717

22861

(3031040) Bacteria [#/volume] in Urine by Automated count

4050

35599

1.42

33.83

5.3

4.5

2234.79

1642.27

e6/l

0.24

444

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

5827

55685

2.39

33.59

15.6

11.7

25.47

25.38

u/l

0.14

5723

54285

(3038026) Centromere Ab [Units/volume] in Serum

132

418

3.21

33.18

1.3

1.2

40.75

53.11

u/ml

—

(3022145) Colonoscopy Study observation

940

6329

1.57

32.71

1.4

—

(3028026) IgM [Mass/volume] in Serum or Plasma

576

3420

1.76

32.70

2.1

1.9

1.38

1.36

g/l

0.06

532

3173

(3004616) Nuclear Ab [Presence] in Serum

190

742

2.61

32.57

1.5

1.3

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

5562

52428

1.79

31.45

5.9

4.9

4.68

4.74

mmol/l

5.22

5293

49541

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

5408

50601

1.67

31.26

5.5

4.9

5.76

5.83

mmol/l

4.31

5069

47095

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

161

595

2.75

30.78

1.3

1.2

65.43

33.76

u/ml

0.71

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

142

491

2.94

30.71

1.3

1.2

96.80

63.06

u/ml

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

5608

53055

1.82

30.40

6.3

5.5

2.73

2.78

mmol/l

5.49

5298

49940

(3021589) Normoblasts [#/volume] in Blood

2905

24398

1.37

30.35

14.0

11.0

0.00

e9/l

0.72

2472

19868

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

5317

49624

1.61

30.04

4.9

4.1

1.25

1.26

mmol/l

0.89

5005

46249

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2817

23616

1.36

29.42

7.2

6.4

1.21

mmol/l

0.34

2617

21913

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2788

23349

1.36

29.24

2.2

2.1

98.23

97.32

pmol/l

0.46

1509

12293

(3019420) Tryptase [Mass/volume] in Serum or Plasma

109

339

3.26

28.27

1.3

1.6

5.96

8.26

ug/l

1.60

102

304

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

5524

52184

1.70

28.12

5.5

4.8

1.51

mmol/l

0.36

5205

49055

(3017732) Neutrophils [#/volume] in Blood

1015

7178

1.50

27.76

3.1

4.21

4.35

e9/l

0.33

901

6304

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2014

16121

1.37

27.69

2.4

2.2

143.29

192.84

u/l

3.43

1886

15313

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

348

1869

1.91

27.26

1.6

1.5

0.91

4.29

iu/ml

0.44

336

(3009445) Proteinase 3 Ab [Units/volume] in Serum

392

2188

1.85

27.25

2.0

1.5

16.76

16.00

iu/ml

0.03

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1797

14157

1.38

27.12

2.6

2.3

2.84

2.74

mg/l

0.78

1576

12314

(3023103) Potassium [Moles/volume] in Serum or Plasma

5613

53328

1.76

27.04

19.7

16.9

3.94

3.95

mmol/l

0.48

5519

52217

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

5399

50804

1.60

26.76

16.6

14.2

82.92

83.80

ml/min/173m2

2.62

5071

46820

(3000963) Hemoglobin [Mass/volume] in Blood

5939

57623

3.05

26.64

28.1

22.8

134.75

134.34

g/l

1.71

5901

57126

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

417

2391

1.80

26.53

2.1

2.0

40.14

39.75

u/l

0.15

382

2168

(3024731) MCV [Entitic mean volume] in Red Blood Cells

5937

57607

3.01

26.36

27.8

22.6

91.23

90.92

6.05

5898

57104

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

5937

57610

3.00

26.30

28.4

23.1

41.91

40.90

0.45

5899

57076

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1442

10993

1.41

26.29

1.8

1.7

43960999.27

33437533.61

pmol/l

0.21

1217

9316

(3019550) Sodium [Moles/volume] in Serum or Plasma

5599

53208

1.73

26.26

19.5

16.8

139.58

139.71

mmol/l

3.59

5518

52202

(3026361) Erythrocytes [#/volume] in Blood

5937

57613

3.00

26.24

27.9

22.7

4.47

e12/l

0.16

5858

56456

(3010813) Leukocytes [#/volume] in Blood

5937

57616

3.00

26.18

27.9

22.7

6.58

6.66

e9/l

1.36

5858

56456

(3035941) MCH [Entitic mass]

5936

57607

2.97

26.06

27.8

22.6

30.37

30.24

6.69

5897

57102

(3007461) Platelets [#/volume] in Blood

5935

57596

2.95

25.99

27.9

22.7

257.39

258.21

e9/l

0.44

5873

56601

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

343

1875

1.88

25.45

1.4

1.3

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1219

9065

1.43

25.45

2.8

2.6

13.86

13.46

umol/l

1.15

1140

8490

(3019150) Specific gravity of Urine by Refractometry

1631

12786

1.38

24.95

5.0

3.9

1.02

1.26

kg/l

0.81

1113

8459

(3020564) Creatinine [Moles/volume] in Serum or Plasma

5807

55909

2.05

24.67

22.9

18.7

74.92

73.20

umol/l

4.06

5767

55295

(3021960) Folate [Moles/volume] in Serum or Plasma

1850

14816

1.36

24.67

1.7

20.25

20.50

nmol/l

0.33

1589

12722

(3036481) Cortisol [Moles/volume] in Serum or Plasma

804

5541

1.52

24.65

2.4

2.3

357.38

377.18

nmol/l

1.68

737

5159

(40768797) Stomach Pathology biopsy report

1064

7777

1.45

24.26

1.3

1.2

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2711

23021

1.32

24.11

2.2

1.9

1.33

1.35

mmol/l

0.90

2321

19554

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

5258

49437

1.50

23.41

6.5

5.9

38.01

38.62

mmol/mol

7.89

4963

46660

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

282

1487

1.94

23.33

2.2

2.1

10.93

11.52

mg/l

0.60

266

1385

(3002179) Metamyelocytes/Leukocytes in Blood

693

4679

1.54

23.29

5.7

4.3

0.74

0.71

0.10

197

1329

(3041096) Erythrocytes [Presence] in Urine by Automated

1966

16004

1.34

23.19

3.7

3.2

0.09

0.15

estimate

0.31

632

4864

(3025159) Blasts/Leukocytes in Blood

705

4796

1.53

22.87

6.3

4.7

0.25

0.29

0.12

177

1137

(3015377) Calcium [Moles/volume] in Serum or Plasma

2269

18892

1.32

22.78

3.3

3.5

2.35

2.36

mmol/l

2.85

2070

17310

(3000850) Epithelial cells [#/volume] in Urine

1499

11736

1.37

22.73

3.3

2.6

6.03

6.55

e6/l

0.42

1382

10683

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2292

19157

1.32

22.22

3.8

3.5

50.93

73.96

ng/l

0.26

1459

12122

(3018418) pH of Serum or Plasma

1962

16067

1.33

21.91

4.9

4.1

7.40

0.27

1402

11469

(3021440) Promyelocytes/Leukocytes in Blood

687

4696

1.52

21.74

6.1

4.6

0.11

0.07

173

1187

(3017181) Myelocytes/Leukocytes in Blood

711

4898

1.51

21.68

6.0

4.5

0.92

0.93

0.02

196

1391

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

309

3.04

21.68

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

157

688

2.32

21.08

1.3

1.2

—

(3019309) Folate [Moles/volume] in Red Blood Cells

1090

8218

1.40

20.52

1.8

1.7

1190.58

1167.38

nmol/l

0.36

832

6364

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1109

8405

1.39

20.21

2.9

2.5

2.38

2.36

g/l

0.46

1022

7798

(3003327) Ova and parasites identified in Stool by Light microscopy

356

2124

1.72

19.68

1.7

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

932

6892

1.42

19.53

1.8

1.6

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

189

924

2.08

19.37

1.3

261.79

451.43

titre

0.45

(3044889) 12 lead EKG panel

4038

36763

1.30

19.10

4.3

3.8

0.23

1531.00

0.49

(3026389) Candida sp identified in Specimen by Organism specific culture

180

869

2.10

19.08

1.4

1.3

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

657

4567

1.49

19.07

1.2

105.46

148.25

u/ml

2.43

281

1746

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1019

7686

1.39

18.99

2.9

2.6

23.35

22.92

0.51

950

7162

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

793

5734

1.44

18.76

4.8

4.5

244.87

242.63

u/l

0.14

753

5446

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

604

4140

1.51

18.75

1.5

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

562

3798

1.53

18.65

1.9

1.7

—

(3025941) Bacteria identified in Stool by Culture

485

3173

1.57

18.61

1.3

1.2

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1718

14064

1.31

18.53

3.1

1004.06

1122.62

ng/l

0.66

1450

12018

(3002582) Erythrocytes [#/volume] in Urine

2029

17049

1.29

17.77

4.0

3.2

51.39

73.32

e6/l

0.40

1606

12896

(36660697) Celiac disease serology panel - Serum

683

4855

1.46

17.64

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

130

569

2.31

17.57

1.3

1.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

593

4105

1.49

17.51

1.2

1.3

—

(3020630) Protein [Mass/volume] in Serum or Plasma

597

4148

1.49

17.30

2.4

2.6

67.26

66.65

g/l

1.22

552

3836

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1544

12552

1.31

17.30

1.9

1.8

0.89

1.12

mg/l

4.34

1154

9722

(3018095) Leukocytes [#/volume] in Urine

2327

19976

1.27

16.90

4.9

3.8

70.97

91.50

e6/l

0.75

1715

13764

(3035933) Granulocytes/Leukocytes in Blood

225

1242

1.84

16.24

4.2

3.3

55.16

57.73

2.43

225

1242

(3026250) Tacrolimus [Mass/volume] in Blood

210

3.12

15.99

47.8

39.5

7.56

7.12

ug/l

1.19

187

(3032080) INR in Blood by Coagulation assay

2630

23029

1.25

15.74

13.7

12.9

1.20

inr

0.10

2218

19104

(3011397) Hemoglobin [Presence] in Urine by Test strip

1613

13333

1.29

15.63

5.0

3.7

0.13

0.17

—

127

(3045414) Leukocytes [Presence] in Urine

723

5311

1.41

15.51

2.1

0.01

0.02

estimate

0.14

154

1119

(3013826) Glucose [Moles/volume] in Serum or Plasma

3430

31017

1.25

15.10

5.5

4.9

6.41

6.57

mmol/l

5.87

3260

29165

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

115

512

2.27

15.00

1.2

—

(3020961) Endomysium IgA Ab [Titer] in Serum

432

2895

1.53

14.85

1.2

1.1

21.67

167.16

titre

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

583

4155

1.45

14.76

2.5

2.4

14.55

21.61

au/ml

2.17

495

(44813793) Dust mix specific IgE antibody measurement

101

428

2.38

14.76

1.1

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

131

621

2.13

14.65

1.1

—

2.47

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

184

986

1.89

14.61

1.5

1.6

0.65

0.73

g/l

0.54

150

760

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

106

465

2.30

14.33

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

111

499

2.25

14.17

1.2

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

878

6756

1.35

14.09

8.0

5.8

1.04

mmol/l

0.19

826

6295

(3048929) Epstein Barr virus Ab [Presence] in Serum

305

1912

1.63

13.99

1.3

1.2

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

542

3850

1.45

13.95

1.3

55.51

51.87

au/ml

0.11

255

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

412

2770

1.52

13.95

2.8

2.2

6320.84

5615.43

u/l

0.17

155

1161

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

109

490

2.25

13.92

1.2

—

(3030467) Casts [#/volume] in Urine by Automated count

1746

14739

1.26

13.92

3.9

3.1

0.28

0.38

e6/l

1.73

1326

10696

(4062490) Immunoglobulin typing, IgG

126

601

2.12

13.89

1.4

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

109

491

2.24

13.86

1.2

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

570

4094

1.43

13.82

4.8

3.7

87.17

85.26

ng/l

0.21

493

3552

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

4076

37735

1.25

13.80

3.7

3.2

45.20

43.56

u/l

0.45

3838

35756

(3045424) Erythrocytes [Presence] in Urine

397

2658

1.53

13.71

2.2

2.1

0.01

0.29

estimate

0.49

137

889

(3033099) Centromere Ab [Titer] in Serum

142

3.40

13.66

1.1

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

761

5780

1.36

13.24

7.0

6.2

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

327

2.50

13.19

1.2

—

(40758558) Short blood count panel - Blood

1935

16614

1.24

13.10

7.2

6.3

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

576

4188

1.42

13.03

2.7

2.4

0.25

0.40

e6/l

2.36

532

3976

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1394

11550

1.27

12.83

1.5

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

264

1632

1.65

12.82

1.3

—

(3018333) Ribosomal P Ab [Presence] in Serum

100

452

2.23

12.65

1.2

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

125

617

2.05

12.62

1.4

3.43

2.89

g/l

1.77

437

(3024139) IgG subclass 3 [Mass/volume] in Serum

125

617

2.05

12.62

1.4

0.52

0.40

g/l

0.41

436

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

192

1093

1.78

12.60

8.6

5.4

219.03

590.10

iu/ml

1.53

146

(3008898) HLA-B27 [Presence]

344

2276

1.54

12.55

1.1

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

4.23

12.42

1.7

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

313

2.48

12.38

1.2

1.3

72.00

66.36

titre

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

103

476

2.18

12.35

1.2

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

124

617

2.03

12.26

1.3

1.4

6.56

6.74

g/l

0.25

436

(3007566) Smooth muscle Ab [Titer] in Serum

265

1660

1.62

12.22

1.2

1.3

60.37

131.30

titre

1.47

161

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2163

18901

1.23

12.17

3.7

3.2

31.89

33.08

u/l

0.37

2047

17910

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

185

2.94

12.10

3.1

8.40

8.93

mg/l

0.23

148

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

196

1137

1.75

12.07

1.4

1.2

282.09

267.75

u/ml

0.23

122

701

(3034770) Mitochondria Ab [Titer] in Serum

264

1663

1.61

11.91

1.2

1240.00

897.14

titre

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

182

2.93

11.83

2.5

2.1

9.08

9.87

mg/l

0.49

154

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

396

2.27

11.72

2.3

2.2

—

(3013512) EKG study

2017

17554

1.22

11.68

3.5

3.4

0.33

0.81

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

199

1172

1.72

11.63

1.6

1.4

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

164

3.00

11.45

2.7

2.4

97.15

126.38

au/ml

0.18

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

546

4021

1.39

11.44

3.8

3.5

4.46

4.49

pmol/l

0.38

494

3635

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

578

4306

1.38

11.30

2.6

2.7

65.90

69.28

ml/min/173m2

1.37

264

1789

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

221

1357

1.65

11.07

1.1

2.72

2.01

u/ml

0.34

120

703

(3027945) Reticulocytes/Erythrocytes in Blood

725

5614

1.33

11.01

2.7

2.6

1.74

1.79

0.77

655

5029

(3042936) Bacteria identified in Isolate by Culture

919

7356

1.29

10.96

2.1

2.0

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1268

10560

1.25

10.93

2.8

2.9

2.43

2.45

mmol/l

3.00

1140

9489

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

4740

45008

1.25

10.89

21.6

18.1

13.55

13.54

0.15

4691

44444

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

141

765

1.86

10.87

1.1

1.46

1.51

g/l

0.80

129

691

(3010375) cycloSPORINE [Mass/volume] in Blood

209

2.70

10.76

24.4

28.5

112.71

117.73

ug/l

0.20

170

(3023520) Reticulocytes [#/volume] in Blood

573

4299

1.37

10.71

2.7

2.6

68.54

70.62

e9/l

0.73

412

3122

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

225

1400

1.63

10.70

1.7

1.5

7.56

15.10

iu/ml

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

613

4649

1.35

10.69

1.6

1.5

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

135

3.13

10.54

2.0

1.6

49.39

131.45

au/ml

—

(3010838) Calcium [Moles/time] in 24 hour Urine

180

1061

1.72

10.52

2.2

2.0

5.01

5.20

mmol/24h

0.33

168

954

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

180

1061

1.72

10.52

1.7

1.4

152.43

155.66

au/ml

0.12

287

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

218

2.63

10.45

1.3

1.2

0.29

0.30

g/l

0.41

177

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

339

2.29

10.44

1.5

1.6

4.79

5.95

u/l

1.97

294

(42529582) MDA5 Ab [Presence] in Serum by Line blot

163

2.90

10.36

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

163

2.90

10.36

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

163

2.90

10.36

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

163

2.90

10.36

1.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

377

2650

1.45

10.26

2.3

2.4

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1382

11691

1.24

10.25

2.1

2.0

—

(3011412) CD3 cells [#/volume] in Blood

104

520

2.02

10.22

2.4

1294.20

1256.54

e6/l

0.17

452

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

155

2.92

10.05

1.9

1.5

8.84

8.87

ug/l

0.01

155

(3042733) HLA Ab [Presence] in Serum

151

2.93

9.89

6.5

5.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

238

1532

1.58

9.86

1.2

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

288

2.34

9.63

2.7

39.91

43.76

0.83

162

(42529406) Shigella sp [Presence] in Stool by Culture

239

1549

1.57

9.62

1.2

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

181

1096

1.67

9.61

1.1

1.39

1.60

u/ml

0.22

100

524

(3002256) Pathology report gross observation

917

7457

1.27

9.56

1.4

1.3

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1200

10072

1.24

9.48

1.8

1.7

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

237

1540

1.56

9.44

1.2

1.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

362

2.17

9.36

1.5

1.4

21.19

19.20

u/ml

0.14

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

237

1544

1.56

9.34

5.5

3.4

1.49

mg/l

0.03

223

1417

(40768446) Kidney Pathology biopsy report

193

2.60

9.05

1.6

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

188

1174

1.62

8.88

1.1

4.10

5.22

u/ml

0.50

598

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

146

856

1.72

8.77

4.1

2.7

792.08

1273.15

u/ml

0.23

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

381

2.09

8.62

2.3

2.6

215.79

224.53

e6/l

0.14

321

(3008401) Mugwort IgE Ab [Units/volume] in Serum

180

1124

1.62

8.52

1.1

1.13

1.24

u/ml

0.10

463

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

516

3962

1.33

8.27

2.1

1.9

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

823

6727

1.26

8.15

2.2

2.0

—

(3000060) B lymphocytes [#/volume] in Blood

165

2.62

7.92

2.4

2.2

0.14

0.16

e9/l

0.18

(3023368) Bacteria identified in Blood by Culture

1552

13570

1.19

7.90

4.2

4.3

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1049

8836

1.23

7.88

3.9

3.4

0.82

mmol/l

0.32

981

8340

(3014051) Protein [Presence] in Urine by Test strip

1819

16129

1.18

7.87

3.3

2.9

0.10

0.04

0.26

318

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

368

2.05

7.86

2.3

2.5

469.38

538.64

e6/l

0.67

294

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

235

1593

1.49

7.76

1.1

10.17

6.67

eliau/ml

0.21

215

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

180

2.51

7.63

1.2

1.1

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

276

1939

1.44

7.60

2.1

2.4

2.84

2.88

g/l

0.27

259

1780

(3026782) Osmolality of Urine

1158

9889

1.21

7.56

3.6

2.8

509.60

521.62

mosm/kgh2o

1.14

1020

8676

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

288

2053

1.42

7.34

2.1

2.3

3.78

3.67

g/l

0.54

270

1896

(21491868) Cryoglobulin [Mass/volume] in Serum

208

2.37

7.33

1.2

—

0.15

g/l

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

288

2054

1.42

7.32

2.1

2.3

4.44

4.25

g/l

0.77

271

1894

(40761536) Microorganisms panel - Urine sediment

565

4468

1.29

7.31

4.8

3.8

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

288

2056

1.42

7.28

2.1

2.3

7.20

7.35

g/l

0.77

271

1895

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

423

3218

1.34

7.24

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

286

2.14

7.23

1.3

1.1

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

134

813

1.66

7.17

1.4

1.3

0.61

4.14

nmol/l

0.78

123

791

(3012494) Peanut IgE Ab [Units/volume] in Serum

156

2.57

7.16

1.0

1.1

4.26

1.88

u/ml

0.26

(37208534) Antinuclear antibody arbitrary concentration in serum

174

2.48

7.14

1.0

1.1

—

(3020779) Urea [Moles/volume] in Serum or Plasma

550

4363

1.29

6.95

10.8

7.5

9.65

9.24

mmol/l

0.74

530

4199

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

145

907

1.61

6.89

1.4

1.2

4.49

3.97

u/ml

0.15

396

(3000570) Elastase.pancreatic [Mass/mass] in Stool

240

1678

1.45

6.82

1.3

1.4

328.88

282.82

ug/g

2.30

127

945

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

167

1084

1.56

6.79

1.5

1.6

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

121

726

1.68

6.78

1.4

1.3

330.26

354.72

pmol/l

0.23

104

632

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

234

1633

1.45

6.72

2.8

3.5

37.35

55.59

mg/l

0.93

193

1393

(3003329) Lymphocytes/Leukocytes in Synovial fluid

447

1.87

6.72

1.4

1.5

30.62

33.34

0.26

260

(3012516) Albumin [Mass/volume] in Urine

1831

16418

1.17

6.67

3.8

3.5

53.37

43.18

mg/l

0.85

1093

10179

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

5.87

6.59

2.4

3.0

1.93

2.42

mg/l

0.49

(3014133) Dog dander IgE Ab [Units/volume] in Serum

153

981

1.57

6.58

1.1

5.56

3.92

u/ml

0.57

461

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

238

2.20

6.57

1.2

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

147

934

1.59

6.57

1.3

1.2

3.54

3.47

u/ml

0.01

347

(3017446) Testosterone [Moles/volume] in Serum or Plasma

402

3081

1.33

6.56

2.5

2.2

12.34

12.30

nmol/l

0.03

364

2770

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

332

2473

1.36

6.55

1.5

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

531

4230

1.28

6.49

4.2

3.7

1.23

mmol/l

1.26

442

3661

(3011985) Renin [Units/volume] in Plasma

127

783

1.64

6.43

1.7

1.5

73.09

64.10

mu/l

0.18

118

706

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

3.92

6.43

2.5

2.2

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

232

1634

1.44

6.36

2.8

3.5

38.75

82.56

mg/l

0.73

189

1398

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

478

1.81

6.32

1.3

2.16

1.58

u/ml

0.20

264

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

244

1741

1.42

6.24

2.5

2.2

301.81

570.11

ug/l

1.22

220

1638

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

117

713

1.65

6.21

1.3

0.18

0.20

nmol/l

0.34

553

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1067

9200

1.19

6.18

3.4

2.8

0.95

1.15

e6/l

0.79

605

4797

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

246

1761

1.41

6.18

2.1

2.3

10.53

10.12

g/l

0.64

227

1587

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

417

1.86

6.16

1.2

—

(3007542) Rye IgE Ab [Units/volume] in Serum

3.96

6.16

1.0

0.78

1.04

u/ml

0.09

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

499

1.77

6.07

1.1

1.2

106.76

111.85

pmol/l

0.45

499

(3009508) Creatinine [Moles/volume] in Urine

1975

17913

1.15

6.04

3.8

3.4

7.28

7.40

mmol/l

0.63

1706

15267

(3018677) aPTT in Platelet poor plasma by Coagulation assay

912

7767

1.21

6.03

2.2

2.1

29.26

29.40

0.30

881

7557

(3037756) Immunofixation for Serum or Plasma

148

963

1.55

6.01

1.5

1.7

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

414

1.85

5.98

1.2

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

876

7438

1.21

5.98

2.3

2.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

304

2273

1.36

5.88

1.6

14.57

13.38

u/ml

0.12

564

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

114

701

1.64

5.87

2.6

2.5

14.92

27.27

iu/ml

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

206

1443

1.44

5.85

2.8

3.3

1.70

2.93

ratio

1.53

118

812

(3004716) Salmonella sp identified in Stool by Organism specific culture

382

2957

1.31

5.83

1.4

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

506

4065

1.27

5.79

1.4

26.14

29.04

iu/l

1.22

437

3513

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

112

689

1.64

5.76

1.3

1.4

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

576

1.70

5.71

1.5

1.6

52.11

56.95

0.50

357

(3020123) Porphyrins [Interpretation] in Serum or Plasma

5.17

5.69

1.1

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

216

1535

1.42

5.68

1.9

2.3

0.01

0.02

g/l

0.25

200

1387

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

130

834

1.57

5.64

1.1

1.0

0.23

0.34

u/ml

0.27

253

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

245

1790

1.38

5.50

2.4

0.76

0.77

g/l

0.02

220

1546

(3020682) Albumin/Creatinine [Ratio] in Urine

1834

16634

1.15

5.50

4.6

4.1

11.08

8.00

mg/mmol

1.19

1097

10135

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

972

8397

1.19

5.47

1.9

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

134

873

1.55

5.45

1.2

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

108

669

1.63

5.43

2.0

1.6

1120.00

2445.71

titre

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

762

6443

1.21

5.42

2.8

2.7

6.75

7.59

umol/l

0.76

664

5612

(3019225) pH of Specimen

592

4879

1.24

5.42

4.3

4.1

7.36

7.35

0.50

427

3458

(3024522) Salmonella sp identified in Specimen by Organism specific culture

109

678

1.62

5.39

1.3

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

109

678

1.62

5.39

1.3

1.4

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

357

1.86

5.35

1.1

1.0

0.24

1.21

u/ml

0.50

(3023430) Cat dander IgE Ab [Units/volume] in Serum

139

918

1.53

5.32

1.1

5.10

3.67

u/ml

0.45

389

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

214

2.11

5.25

3.8

4.4

—

(3037121) Protein [Mass/volume] in Urine

232

1697

1.38

5.19

4.1

3.3

345.59

407.05

mg/l

0.27

111

700

(3020876) Protein [Mass/time] in 24 hour Urine

592

1.65

5.19

2.2

2.4

1.42

1.30

g/24h

0.11

344

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

258

1921

1.36

5.17

2.4

1.8

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

3.34

5.15

1.2

1.0

—

(3009871) Measles virus Ab [Titer] in Serum

229

2.06

5.15

1.6

1.7

6217.14

3357.84

titre

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

203

2.13

5.12

1.1

1.0

15.52

10.65

u/ml

0.42

135

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

127

2.45

5.11

1.0

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

143

960

1.50

5.09

1.1

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

464

3753

1.26

5.04

2.4

2.3

7.32

6.82

ug/l

0.10

408

3334

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

610

5085

1.22

5.01

2.5

2.3

0.22

0.21

g/l

0.97

565

4778

(3052851) Hemolysis interference index of Serum or Plasma

197

1412

1.41

4.98

2.7

3.1

1.73

1.98

index

0.23

718

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

582

4839

1.22

4.91

2.2

2.0

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1170

10350

1.16

4.88

5.6

5.5

1.97

2.75

ug/l

4.22

1048

9375

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

3.34

4.88

1.1

2.06

2.02

iu/ml

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

397

3170

1.27

4.82

4.1

3.6

5.01

5.15

kpa

3.88

378

3050

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

551

1.64

4.79

1.4

1.2

—

(1761868) Lipid panel - Serum or Plasma

2403

22331

1.13

4.77

3.3

2.9

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

102

646

1.59

4.74

1.3

1.4

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

617

5180

1.21

4.73

3.1

3.2

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

238

1.98

4.67

1.2

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

2.84

4.64

1.0

1.1

0.02

0.05

u/ml

0.74

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

135

914

1.49

4.64

1.2

1.1

—

8.25

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

102

653

1.57

4.54

1.3

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

102

655

1.57

4.49

1.3

1.4

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

288

2228

1.31

4.49

1.6

1.8

1.42

1.52

g/l

1.03

257

1929

(3020874) Milk IgE Ab [Units/volume] in Serum

401

1.73

4.48

1.1

0.45

1.99

u/ml

0.94

120

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

3.15

4.48

1.1

1.0

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

439

1.69

4.46

1.5

1.4

30815.19

69045.84

e6/l

0.80

300

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

288

2230

1.31

4.46

1.7

1.8

3.99

4.19

mg/l

0.15

233

1645

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1104

9788

1.16

4.44

3.9

3.6

254.06

490.57

ng/l

1.23

747

7053

(3010503) CD19 cells [#/volume] in Blood

321

1.81

4.44

2.5

211.21

219.10

e6/l

0.03

308

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

201

1479

1.37

4.40

1.9

2.3

0.00

g/l

0.50

178

1299

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

123

828

1.50

4.38

1.2

1.1

1.71

0.84

—

(3004809) Band form neutrophils/Leukocytes in Blood

118

788

1.51

4.36

4.6

3.5

1.71

1.53

0.16

105

720

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

382

1.74

4.36

1.1

1.2

1.04

1.06

ratio

0.78

306

(3009343) pH of Capillary blood

381

3067

1.26

4.34

4.1

3.7

7.42

0.01

310

2548

(3014599) Egg white IgE Ab [Units/volume] in Serum

391

1.72

4.30

1.1

1.0

4.35

1.38

u/ml

0.36

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

179

1299

1.39

4.27

1.3

4.07

32.31

e6/l

3.51

138

941

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

261

1.88

4.24

1.1

94.00

91.53

0.19

208

(3019832) Treponema pallidum Ab [Presence] in Serum

765

6615

1.18

4.23

1.9

1.8

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

187

1369

1.38

4.23

1.9

2.4

0.00

g/l

-0.00

178

1296

(3009214) Lutropin [Units/volume] in Serum or Plasma

221

1662

1.34

4.22

1.4

9.65

11.89

u/l

1.76

176

1378

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

181

1320

1.38

4.20

1.4

271.45

4669.58

e6/l

0.87

146

1024

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

211

1577

1.35

4.20

1.2

3.40

4.00

0.37

223

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

3.42

4.18

1.1

0.41

0.58

iu/ml

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

128

882

1.46

4.08

1.8

1.7

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

116

2.33

4.07

1.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

399

1.69

4.02

1.4

1.2

65.32

86.00

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

369

1.71

4.02

1.0

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

129

894

1.45

4.00

2.2

5.14

6.35

umol/l

0.73

652

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

176

2.05

3.99

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

190

2.01

3.96

1.1

1.2

94.68

91.14

0.24

(3000475) Leukocytes [#/volume] in Synovial fluid

173

1267

1.38

3.94

1.7

1.6

9314.85

10796.28

e6/l

0.24

131

879

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

185

2.01

3.87

1.2

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

114

777

1.48

3.86

1.6

375.61

360.46

mu/l

0.15

618

(3024471) HLA-A [Type]

145

2.14

3.85

1.0

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

633

1.52

3.82

1.7

1.6

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

2.68

3.81

1.1

1.0

—

(4268621) Lupus anticoagulant assay

650

1.52

3.79

2.4

2.3

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

183

1365

1.35

3.73

1.8

1.6

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

195

1.95

3.71

1.1

90.68

90.25

0.03

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

333

1.72

3.70

1.1

1670.39

1481.91

miu/ml

0.68

333

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

783

6859

1.16

3.69

1.6

1.5

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

2.69

3.65

1.0

0.01

0.13

u/ml

0.72

(3024932) HLA-DR beta [Type]

142

2.12

3.64

1.0

1.1

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

210

1606

1.32

3.62

2.7

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

200

1521

1.33

3.59

1.4

1.3

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

2.57

3.54

1.1

1.91

0.75

u/ml

0.38

(3028433) Virus identified in Specimen by Culture

164

2.02

3.53

1.1

1.2

—

(3049717) Cytology report of Urine Cyto stain

206

1579

1.32

3.51

2.6

2.5

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

142

1029

1.39

3.49

1.5

1.4

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

216

1669

1.31

3.48

3.7

2.6

3.39

3.60

g/l

1.65

207

1584

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

139

1007

1.39

3.43

1.6

1.4

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

176

1324

1.34

3.42

1.3

1.2

3.67

3.72

mmol/l

0.29

167

1257

(3039744) RNA polymerase III Ab [Units/volume] in Serum

2.98

3.41

1.1

—

3.79

—

(3011897) Casein IgE Ab [Units/volume] in Serum

2.35

3.40

1.1

1.2

0.16

5.33

u/ml

0.49

(3042111) Morphology [Interpretation] in Bone marrow Narrative

117

825

1.43

3.37

1.8

1.7

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

2.50

3.37

1.1

1.2

45.07

43.51

mg/l

0.05

(3023419) Bacteria identified in Sputum by Culture

660

1.48

3.36

2.6

—

(3001218) Citrate [Mass/time] in 24 hour Urine

7.01

3.36

2.0

1.3

421.14

414.70

mg/24h

—

(21494890) Protein electrophoresis panel - 24 hour Urine

460

1.57

3.34

1.7

2.0

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

359

2967

1.22

3.29

6.9

7.0

24.43

24.46

mmol/l

0.06

341

2840

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

2.54

3.29

2.9

3.1

33.74

24.45

mg/l

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

161

1204

1.35

3.27

1.6

1.4

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

700

6144

1.16

3.22

1.9

1.8

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

103

2.24

3.21

1.1

1.0

0.03

1.18

u/ml

0.64

(3020911) Cortisol [Moles/time] in 24 hour Urine

213

1.84

3.21

1.7

1.3

781.57

116.33

nmol/24h

0.45

213

(3003181) Sodium [Moles/volume] in Urine

129

935

1.39

3.20

1.3

1.4

62.84

63.42

mmol/l

0.05

100

745

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

325

2669

1.23

3.18

3.9

3.5

0.95

1.82

mmol/l

3.97

224

1973

(3045716) Anion gap in Serum or Plasma by calculation

506

1.53

3.17

2.9

3.1

9.92

10.66

mmol/l

1.17

499

(4027681) Cerebrospinal fluid IgG ratio and IgG index

372

1.62

3.17

1.3

1.2

0.51

0.61

ratio

2.84

228

(3042631) Mycobacterium sp identified in Specimen

628

1.47

3.16

2.7

2.9

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

317

2601

1.23

3.13

1.3

1.4

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

426

3605

1.20

3.07

3.1

2.8

135.48

168.26

ng/l

1.49

385

3289

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

133

976

1.37

3.07

1.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

178

1365

1.31

3.07

1.4

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

192

1488

1.30

3.07

1.3

467.10

526.28

mg/l

1.34

184

1425

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

535

1.50

3.05

1.1

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

663

5823

1.16

3.04

1.9

1.8

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

923

8292

1.13

3.03

4.9

4.5

22.60

21.80

0.90

451

4056

(4195642) Thrombophilia screening test

119

860

1.39

3.02

1.2

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

440

1.55

3.02

1.3

1.2

188.46

197.21

titre

0.03

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

171

1310

1.31

2.98

1.8

1.6

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

208

1644

1.27

2.87

3.1

2.5

181.16

187.51

0.47

196

1573

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

610

5349

1.16

2.86

2.6

2.4

47.68

37.43

u/l

0.74

511

4493

(1616796) Gas panel - Central venous blood

148

1119

1.33

2.85

4.0

3.6

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

4632

45201

1.11

2.81

22.9

18.8

332.28

331.89

g/l

2.38

4610

44965

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

747

6654

1.14

2.80

1.7

1.41

1.42

0.07

637

5904

(3005033) Fetal Nuchal fold Thickness US

111

1512

0.73

2.79

1.5

1.19

1.26

1.33

1091

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

120

882

1.37

2.78

2.0

1.9

189.86

194.14

pmol/l

0.16

115

827

(44806420) Estimation of glomerular filtration rate

101

722

1.41

2.76

2.7

2.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

117

1578

0.74

2.76

1.5

1.6

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

426

1.53

2.76

2.0

2.1

19.46

19.17

nmol/l

0.09

403

(4024509) Urine culture

311

2585

1.21

2.75

2.1

1.9

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

118

867

1.37

2.75

1.1

117.25

117.59

0.04

106

788

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

270

2213

1.23

2.73

1.4

1.3

176.83

231.91

miu/ml

2.10

123

1047

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

132

989

1.34

2.71

1.5

1.7

—

(3045462) Protein/Creatinine [Ratio] in Urine

2.71

8.2

4.6

19.87

41.49

mg/mmol

0.61

(3047007) Chlamydophila sp Ab [Presence] in Serum

118

869

1.37

2.71

1.3

1.2

—

(3019060) Gas panel - Arterial blood

338

2840

1.20

2.67

4.8

5.1

—

(3008295) Osmolality of Serum or Plasma

568

1.45

2.67

1.4

280.33

277.75

mosm/kgh2o

0.48

434

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

175

1.83

2.67

2.5

2.7

0.61

mmol/l

0.07

175

(3021447) Carbon dioxide [Partial pressure] in Venous blood

554

4855

1.16

2.64

6.3

3.9

5.81

kpa

0.05

543

4730

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

3.15

2.64

1.6

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

114

1531

0.74

2.63

1.5

—

(21494814) CD8 cells/Lymphocytes in Specimen

213

1.74

2.62

2.2

29.24

29.88

0.08

213

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

2.46

2.61

1.0

0.02

0.75

u/ml

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

191

1.78

2.61

2.0

2.3

1.02

1.07

ug/l

0.04

182

(3012501) Base excess in Blood by calculation

134

1013

1.33

2.61

3.7

4.1

2.07

2.53

mmol/l

1.35

677

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

424

1.51

2.60

1.5

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

424

1.51

2.60

1.5

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

424

1.51

2.60

1.5

1.6

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

199

1.76

2.59

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

482

1.48

2.58

2.7

3.3

14.83

13.60

index

0.23

279

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

245

2005

1.23

2.54

1.9

—

32.21

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

2.42

2.53

1.0

0.02

0.03

u/ml

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

280

2324

1.21

2.53

1.7

260.68

295.18

mu/l

2.09

258

2087

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

218

1763

1.25

2.52

2.3

2.1

2.42

6.81

iu/l

0.84

774

(3034891) Synovial lining cells/cells in Synovial fluid

246

1.67

2.52

1.4

4.86

3.67

—

(3003740) Influenza virus B Ag [Presence] in Specimen

146

1124

1.31

2.51

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

146

1124

1.31

2.51

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

309

1.59

2.49

1.2

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

137

1048

1.31

2.48

1.2

1.1

9.89

16.87

au/ml

0.97

265

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

116

867

1.34

2.46

1.1

3.33

3.08

eliau/ml

0.11

423

(4281824) Cell count and differential, peritoneal fluid

695

0.63

2.45

1.1

1.2

—

(3047181) Lactate [Moles/volume] in Blood

185

1474

1.26

2.45

6.1

6.2

1.26

mmol/l

0.01

168

1297

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

604

1.41

2.45

4.8

5.4

61.48

82.16

u/ml

0.23

187

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

692

6192

1.13

2.44

3.5

3.3

0.73

0.77

ug/l

0.42

448

4066

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.09

2.42

1.2

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.09

2.42

1.2

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.09

2.42

1.2

1.1

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

391

1.51

2.42

1.9

1.6

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

112

835

1.35

2.42

1.1

4.44

2.79

0.71

148

(3012544) pH of Venous blood

557

4918

1.15

2.41

6.4

3.9

7.37

7.38

0.22

301

2763

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

120

905

1.33

2.40

1.1

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

5.00

2.40

2.3

2.2

26.50

24.85

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

124

1.94

2.39

1.4

1.1

—

(3044290) Cell count panel - Cerebral spinal fluid

156

1221

1.29

2.39

1.3

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

3.34

2.39

1.9

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

953

0.69

2.39

1.3

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

131

1002

1.31

2.38

2.5

2.4

44.81

78.65

ug/min

1.28

601

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

217

1767

1.24

2.38

2.6

2.2

94.69

94.58

0.02

200

1710

(3001964) Herpes simplex virus Ag [Presence] in Specimen

153

1.83

2.37

2.1

1.4

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

321

1.56

2.37

1.3

—

(3036525) Urea [Moles/time] in 24 hour Urine

3.64

2.36

2.4

2.8

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

469

1.46

2.31

1.1

1.0

289.46

293.95

mg/l

0.13

429

(3022313) Gas panel - Capillary blood

258

2147

1.21

2.30

4.5

3.7

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

112

1.97

2.30

1.3

1.1

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

2.12

2.28

2.2

8.5

71.50

67.70

0.23

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

655

1.38

2.28

1.9

1.6

—

(21494434) Karyotype in Bone marrow

423

1.47

2.24

1.3

1.2

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

300

2541

1.19

2.22

6.2

3.0

0.60

0.62

0.59

300

2526

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

3.11

2.22

1.1

3.01

2.62

u/ml

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

194

1.70

2.22

3.5

3.4

1.11

1.44

0.88

194

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

287

1.57

2.21

1.5

1.9

0.74

1.64

u/ml

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

2.34

2.21

1.0

0.01

0.08

u/ml

—

(3024354) Oxygen [Partial pressure] in Venous blood

461

4045

1.15

2.20

5.8

3.3

4.55

4.57

kpa

0.10

450

3938

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2706

25957

1.08

2.19

2.9

2.7

—

estimate

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

492

1.43

2.18

1.2

1.1

41.78

38.74

mg/l

0.13

423

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

122

1.89

2.15

1.0

2.0

2.84

2.12

ug/l

0.20

(3022689) Creatine [Moles/volume] in Urine

181

1.72

2.14

2.1

1.4

7.19

8.32

mmol/l

0.56

181

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

395

1.47

2.13

1.2

1.1

—

1.33

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

306

1.54

2.13

1.4

1.5

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

167

1.74

2.10

3.4

2.8

29.78

28.51

umol/l

0.27

115

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

479

1.42

2.10

1.1

250.40

240.99

mg/l

0.15

426

(4015189) Microbial culture of sputum

109

1.93

2.10

2.5

2.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

190

1.69

2.09

1.1

1.2

—

5.00

—

(3036489) Thrombin time

251

2107

1.20

2.08

2.5

2.0

20.58

20.78

0.22

203

1838

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

420

3680

1.15

2.06

2.2

3.7

35.57

57.73

u/ml

2.43

403

3562

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

269

1.57

2.05

1.1

9.08

7.47

u/ml

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.98

2.05

1.8

1.6

—

0.86

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

626

1.36

2.04

1.0

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

693

6274

1.12

2.04

5.0

4.7

32.50

32.52

0.02

500

4260

(3016228) CD19 cells/cells in Blood

215

1.63

2.02

2.1

10.34

7.46

0.61

206

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

235

1966

1.20

2.02

2.0

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

118

1.87

2.01

1.3

1.2

90.00

79.63

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

2.82

2.00

1.7

325.22

313.00

umol/24h

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

1.96

1.99

1.1

1.0

0.70

4.08

u/ml

0.68

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

163

1.72

1.97

2.3

2.0

1.73

1.79

ratio

0.08

154

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

587

1.37

1.97

1.1

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

119

1.85

1.96

1.2

85.83

70.30

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

112

866

1.30

1.94

1.3

1.2

23.66

35.91

u/l

1.23

101

746

(3032057) Clostridioides difficile [Presence] in Stool

1.98

1.94

1.8

2.1

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

910

8380

1.10

1.94

3.7

3.0

2.95

3.23

e6/l

0.22

437

3961

(3000012) Reticulocyte production index

675

1.34

1.94

2.0

2.1

0.99

0.89

0.88

452

(42528597) U1 small nuclear ribonucleoprotein C Ab [Presence] in Serum by Line blot

3.75

1.93

1.0

—

(42528596) U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot

3.75

1.93

1.0

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

3.75

1.93

5.3

2.6

—

(3002079) Sodium [Moles/time] in 24 hour Urine

258

1.55

1.91

1.6

1.3

147.32

151.55

mmol/24h

0.13

258

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

203

1.63

1.91

1.2

1.1

—

(3045142) Bone marrow Pathology biopsy report

582

1.36

1.91

1.5

1.4

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

372

1.46

1.90

1.1

1.0

0.91

1.16

u/l

5.37

151

(3036670) Protein [Mass/volume] in Synovial fluid

128

1.80

1.89

1.1

1.2

36.12

38.18

g/l

0.22

(3037692) Legionella sp identified in Specimen by Organism specific culture

173

1.68

1.89

1.9

1.4

—

(3022806) Fractional oxyhemoglobin in Capillary blood

592

1.36

1.88

1.7

1.8

90.53

90.03

0.45

582

(3028679) Herpes simplex virus Ab [Presence] in Serum

340

1.47

1.88

1.3

1.2

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

201

1671

1.21

1.87

4.7

3.8

24.32

24.89

mmol/l

2.38

185

1554

(3000034) Microalbumin [Mass/volume] in Urine

440

1.41

1.87

4.4

2.9

68.08

33.29

mg/l

0.68

315

(3025549) Creatine [Moles/time] in 24 hour Urine

2.65

1.86

1.1

1.4

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

449

1.41

1.86

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

129

1.79

1.85

1.1

1.2

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

100

1.90

1.85

1.1

0.56

0.68

umol/24h

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

4.17

1.82

5.2

5.0

317.40

337.92

umol/l

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

102

787

1.30

1.82

1.5

1.4

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

2.27

1.80

1.0

0.01

2.25

u/ml

—

(3020393) Adenovirus Ag [Presence] in Stool

2.27

1.80

1.5

1.3

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

385

1.43

1.80

6.7

7.3

8.43

83.43

ug/l

0.99

249

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.06

1.80

2.0

1.7

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

128

1020

1.26

1.78

1.2

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

255

1.53

1.78

1.5

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

255

1.53

1.78

1.5

1.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

255

1.53

1.78

1.5

1.7

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

643

1.33

1.76

1.1

—

4.75

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

150

1835

0.81

1.76

1.4

1.5

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

256

1.53

1.75

1.4

1.7

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

2.22

1.73

1.8

2.2

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

296

2568

1.16

1.71

6.2

3.1

1.16

1.25

0.81

296

2551

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

467

1.37

1.68

1.2

1.1

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

2.18

1.67

1.0

0.00

0.50

u/ml

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

292

1.48

1.66

1.6

1.7

1.66

6.28

nmol/l

1.68

227

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

318

0.56

1.66

1.2

1.1

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

3.16

1.66

3.5

2.7

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

153

1855

0.82

1.66

1.4

1.5

0.92

0.95

ratio

0.52

1115

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

153

1855

0.82

1.66

1.4

1.5

1.10

1.21

ratio

0.82

100

1121

(3001019) Free T4 and TSH panel - Serum or Plasma

387

3432

1.14

1.65

1.8

1.7

—

(3039000) Anion gap in Blood by calculation

124

996

1.25

1.64

7.2

7.6

11.54

11.18

mmol/l

0.62

113

890

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

385

1.41

1.63

1.5

1.6

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

153

1851

0.82

1.63

1.4

1.5

1.10

1.16

ratio

0.31

1111

(3018572) Chloride [Moles/volume] in Blood

124

997

1.25

1.63

7.2

7.6

104.78

105.36

mmol/l

0.61

113

891

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

212

1800

1.18

1.61

1.9

—

(42528595) U1 small nuclear ribonucleoprotein 70kD Ab [Presence] in Serum by Line blot

3.57

1.61

1.0

—

(3016018) Differential panel - Cerebral spinal fluid

679

1.30

1.61

1.3

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.15

1.61

1.0

1.1

0.04

0.03

u/ml

0.40

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

166

1988

0.83

1.59

1.5

62.63

61.55

ug/l

0.11

141

1659

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

2.33

1.58

1.0

2.02

5.22

u/ml

—

(3017354) Segmented neutrophils/Leukocytes in Blood

507

1.35

1.58

3.9

3.5

58.67

57.94

0.09

447

(3019977) pH of Arterial blood

624

5707

1.10

1.56

7.5

8.1

7.42

0.02

361

3097

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

604

1.31

1.55

2.1

23.57

21.98

mg/l

0.13

223

(3013166) Neutrophils/Leukocytes in Synovial fluid

137

1.68

1.54

1.5

1.3

43.63

49.37

0.33

115

(3050129) First trimester maternal screen panel - Serum or Plasma

196

2305

0.85

1.54

1.4

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

174

1459

1.20

1.54

1.7

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

2.03

1.54

13.5

12.5

5.30

5.43

mmol/l

0.06

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

450

1.36

1.52

2.3

1.7

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

365

1.40

1.52

1.1

6.56

13.07

nmol/l

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

295

2585

1.15

1.52

1.5

—

(44806071) Cardiolipin IgM antibody measurement

1.83

1.51

1.0

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

177

1.58

1.51

1.1

1.2

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

291

1.45

1.50

1.5

—

(3023410) Appearance of Cerebral spinal fluid

608

1.30

1.49

1.4

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

248

2151

1.16

1.48

5.4

5.2

1.57

1.60

0.21

235

2030

(40762887) Creatinine [Moles/volume] in Blood

2.43

1.47

1.6

—

(44790049) Parainfluenza type 3 nucleic acid detection

671

1.29

1.47

1.9

1.5

—

(44790048) Parainfluenza type 2 nucleic acid detection

671

1.29

1.47

1.9

1.5

—

(44790047) Parainfluenza type 1 nucleic acid detection

671

1.29

1.47

1.9

1.5

—

(44806118) Parainfluenza type 4 nucleic acid detection

671

1.29

1.47

1.9

1.5

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

229

1976

1.17

1.46

1.4

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

558

1.31

1.45

1.4

1.6

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

506

1.33

1.45

1.5

1.7

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.12

1.44

1.1

1.59

1.66

umol/24h

0.15

(3025886) Oxalate [Mass/time] in 24 hour Urine

3.13

1.44

1.2

43.66

35.69

mg/24h

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

2.73

1.43

1.0

1.1

0.05

0.04

u/ml

—

(3002032) Base excess in Venous blood by calculation

520

4738

1.11

1.42

6.6

3.9

1.62

1.83

mmol/l

0.74

466

4166

(3007930) Methemoglobin/Hemoglobin.total in Blood

227

1964

1.16

1.41

5.8

5.6

0.87

0.89

0.34

215

1851

(3027801) Oxygen [Partial pressure] in Arterial blood

620

5707

1.10

1.38

7.5

8.1

12.28

12.70

kpa

1.32

594

5506

(3003396) Base excess in Arterial blood by calculation

616

5670

1.10

1.37

7.4

8.0

0.88

0.90

mmol/l

0.04

484

4673

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

297

1.42

1.37

1.1

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

2.61

1.36

1.7

1.5

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

138

1148

1.21

1.36

1.4

1.3

29.30

28.72

u/l

0.06

108

949

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

619

5706

1.09

1.34

7.5

8.1

5.04

5.09

kpa

0.71

591

5506

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

120

1.67

1.33

1.2

1.3

—

(3044640) Blood type and Crossmatch panel - Blood

1864

17894

1.06

1.33

2.4

2.3

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

172

1464

1.18

1.32

3.0

3.5

0.36

0.35

iu/ml

0.16

796

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

2.50

1.30

1.0

1.1

0.01

0.04

u/ml

—

(3016502) Oxygen saturation in Arterial blood

550

5051

1.10

1.30

7.9

8.5

95.79

95.81

0.03

533

4887

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

209

1.49

1.29

1.7

1.5

14.07

14.60

pmol/l

0.37

173

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

106

1.70

1.29

1.5

1.2

0.89

95.42

mg/l

0.99

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

145

1.59

1.28

3.1

3.7

9.73

10.46

kpa

0.52

145

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

145

1.59

1.28

3.1

3.7

4.89

4.88

kpa

0.02

145

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

517

1.30

1.28

1.4

1.3

1.77

1.48

nmol/l

1.21

470

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

114

1.67

1.28

3.0

2.0

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

302

1.39

1.26

1.2

7.95

10.05

mm/h

0.90

302

(3016038) Potassium [Moles/volume] in Urine

336

1.37

1.26

1.1

37.02

33.88

mmol/l

0.34

299

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

217

1891

1.15

1.26

1.9

2.0

2.23

2.00

ug/l

0.10

191

1696

(3028707) Methadone [Presence] in Urine by Screen method

1014

0.80

1.25

1.4

2.7

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

337

1.37

1.24

1.3

1.2

77.60

84.80

u/l

0.31

292

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

261

1.42

1.24

1.4

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

253

1.43

1.23

2.0

1.7

1.65

3.49

u/field

0.98

178

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

381

1.34

1.23

1.2

1.1

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

2.63

1.21

1.8

1.6

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

2.63

1.21

2.4

3.7

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

469

1.30

1.21

1.2

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.80

1.21

1.0

1.1

—

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

124

1.61

1.20

1.4

1.3

33.93

37.35

0.14

(3044927) Protein electrophoresis panel - Urine

471

1.30

1.18

1.2

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

410

1.32

1.18

1.4

1.3

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

117

1.63

1.17

1.4

1.1

214.62

277.60

pmol/l

0.75

(3022493) Free Hemoglobin [Mass/volume] in Plasma

198

1.47

1.16

1.1

5.4

47.85

66.56

mg/l

1.79

146

(40768800) Prostate Pathology biopsy report

680

0.76

1.16

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

265

1.40

1.16

1.1

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

644

1.25

1.12

6.3

6.9

11.58

11.86

mg/l

0.26

606

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

175

1.49

1.12

1.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

250

1.40

1.12

10.2

5.7

32.50

58.16

u/ml

—

(3018133) Calcium [Moles/volume] in Urine

111

1.62

1.11

1.7

1.8

2.32

2.93

mmol/l

1.37

100

(4198724) Urine methamphetamine measurement

232

0.60

1.09

1.4

3.9

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.95

1.08

1.1

1.2

—

(3023183) Ammonium ion [Moles/volume] in Plasma

126

1067

1.18

1.08

3.5

2.8

35.18

34.52

umol/l

0.13

120

978

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

329

1.34

1.08

1.5

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

129

1095

1.18

1.08

2.6

3.6

129.68

693.89

u/ml

1.48

115

1000

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

330

1.34

1.06

1.4

1.2

14.43

23.99

u/l

1.31

279

(3027273) Bicarbonate [Moles/volume] in Venous blood

235

2088

1.13

1.06

5.0

3.2

24.99

25.30

mmol/l

0.68

227

2006

(3000330) Specific gravity of Urine by Test strip

230

2586

0.89

1.06

4.2

3.2

1.02

ratio

2.40

199

2315

(3016879) Cocaine [Presence] in Urine

194

2205

0.88

1.06

1.3

2.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

105

1.62

1.05

3.0

2.3

44.29

37.93

ug/l

0.04

105

(3033658) Prothrombin time (PT) actual/Normal

1432

13732

1.06

1.05

4.4

3.9

92.34

92.75

0.26

1388

13426

(40768793) Breast Pathology biopsy report

189

1657

1.15

1.05

1.3

—

(3017704) Immunofixation for Urine

245

1.39

1.05

1.9

1.6

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

1.79

1.04

2.2

2.3

0.58

1.12

mmol/l

—

(3041806) Other cells [#/volume] in Blood by Manual count

187

1.45

1.03

1.5

1.6

0.49

0.48

e9/l

0.08

187

(44816559) Phosphatidylethanol [Mass/volume] in Blood

260

2331

1.12

1.02

1.5

1.7

0.33

0.31

mg/l

0.21

134

1028

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

171

1.46

1.02

1.2

1.4

123.02

123.75

nmol/l

0.01

125

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

316

3478

0.90

1.01

1.5

1.6

985.20

999.17

mu/l

0.11

273

2917

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

171

1494

1.15

1.01

1.4

1.3

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

422

1.28

0.99

1.1

16.99

16.77

u/ml

0.02

191

(3038071) Oxygen [Partial pressure] in Mixed venous blood

107

1.59

0.99

11.4

7.5

7.17

5.39

kpa

0.68

107

(3024263) Appearance of Synovial fluid

248

1.37

0.99

1.6

1.8

—

(1002224) Polysomnography panel

309

2804

1.11

0.99

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

212

0.61

0.97

2.5

2.4

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

198

1.42

0.97

1.0

1.1

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.95

0.97

1.0

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

117

997

1.18

0.96

1.2

1.4

2.71

3.58

ug/l

1.53

883

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

0.00

0.96

0.0

1.1

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

649

1.22

0.96

1.1

100.95

96.80

0.59

612

(3002173) Hemoglobin [Mass/volume] in Arterial blood

511

4753

1.08

0.96

8.5

8.9

121.13

120.89

g/l

0.09

499

4645

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

1.69

0.95

1.3

79.08

51.63

ng/l

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

340

0.70

0.93

1.3

1.7

—

(37021550) Renin [Units/volume] in Plasma --upright

109

1.56

0.93

1.1

1.3

50.78

51.71

mu/l

0.01

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

217

1.38

0.93

1.3

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

217

1.38

0.93

1.3

1.4

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

1.67

0.91

7.3

6.9

11.32

10.47

0.63

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

599

1.22

0.91

1.3

1.2

55.73

56.65

u/l

0.07

531

(3024891) Influenza virus A+B Ag [Presence] in Specimen

168

1481

1.14

0.90

1.1

—

(3000764) Benzodiazepines [Presence] in Urine

213

2376

0.89

0.90

1.3

2.1

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

2.07

0.89

4.2

1.4

144.33

181.00

ug/g

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.07

0.89

1.0

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

165

1868

0.88

0.89

1.3

2.1

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

246

1.34

0.87

1.6

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

246

1.34

0.87

1.6

1.5

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

281

1.32

0.86

2.1

1.8

—

(40765096) Chromosome analysis panel by Banding

161

1.43

0.86

1.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

468

1.24

0.85

4.0

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.59

0.84

1.4

—

(4035726) Immunohistochemistry procedure

512

4794

1.07

0.83

1.4

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

113

0.53

0.83

1.5

1.3

75.67

67.48

ug/l

—

113

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.69

0.82

1.2

1.4

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

249

1.33

0.81

1.1

1.2

1580.00

1030.61

titre

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

155

1.42

0.80

1.2

1.5

—

(3027944) Amphetamines [Presence] in Urine

214

2366

0.90

0.79

1.3

2.0

—

(3025130) Human papilloma virus identified in Specimen

134

1176

1.14

0.79

1.8

1.9

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.00

0.79

0.0

1.1

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.82

0.79

2.0

2.2

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.79

0.0

1.0

—

(40763590) HLA-DQ beta [Type]

0.00

0.79

0.0

1.0

—

(40760409) HLA-A [Type] by High resolution

0.00

0.79

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

0.79

0.0

1.0

—

(3013862) HLA-DP [Type]

0.00

0.78

0.0

1.0

—

(3025577) Chromium [Mass/volume] in Blood

251

1.32

0.78

2.3

2.2

3.40

2.73

ug/l

0.36

212

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

685

1.18

0.77

1.2

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

328

3032

1.09

0.76

6.4

3.3

131.26

129.39

g/l

0.89

319

2939

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

332

1.27

0.75

1.2

1.1

10.13

20.79

u/l

3.47

296

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

235

1.32

0.75

1.2

1.4

207.10

191.08

pmol/l

0.14

235

(3006270) Folate [Moles/volume] in Blood

413

1.24

0.75

1.2

1.1

356.05

381.94

nmol/l

0.45

373

(3028300) Cannabinoids [Presence] in Urine

218

2399

0.91

0.75

1.3

2.1

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

2.08

0.74

3.0

4.8

—

(3029396) Erythrocyte agglutination [Presence] in Blood

184

0.65

0.73

2.4

3.1

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

469

1.22

0.73

1.1

4.96

8.90

iu/ml

1.47

141

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

335

1.26

0.71

1.2

1.1

64.46

77.76

u/l

1.34

299

(3027008) Opiates [Presence] in Urine

218

2390

0.91

0.71

1.3

1.9

—

(3036048) Francisella tularensis Ab [Titer] in Serum

126

1.43

0.70

1.2

1.1

—

222.86

—

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

1.71

0.70

1.0

0.04

0.29

u/ml

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.55

0.69

1.2

1.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

156

1398

1.12

0.69

1.5

1.3

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

114

1002

1.14

0.69

1.8

1.5

—

(3040151) Glucose [Moles/volume] in Capillary blood

537

1.19

0.69

2.3

4.2

6.97

7.08

mmol/l

0.11

446

(40765089) Chromosome analysis panel - Blood by G-banded

170

1.35

0.67

1.0

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.54

0.67

1.4

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

549

1.19

0.66

1.4

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

331

1.24

0.64

2.7

1.9

103.53

104.09

ng/l

0.01

331

(4034850) Laboratory test

180

1634

1.10

0.64

10.6

9.3

—

(40768441) Liver Pathology biopsy report

431

1.21

0.64

1.4

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.47

0.64

1.2

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

476

4499

1.06

0.63

9.1

8.0

1.24

1.30

mmol/l

0.78

464

4419

(3002619) Bacteria identified in Specimen by Culture

138

1.38

0.62

1.4

1.3

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.67

0.61

1.2

—

(3014271) Vancomycin [Susceptibility]

182

1.32

0.61

3.0

2.9

—

(3019174) dRVVT (LA screen)

1.57

0.60

1.0

1.2

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.60

0.0

1.0

—

(3008536) Aspergillus sp Ab [Presence] in Serum

105

1.43

0.60

1.5

1.9

—

(3052592) Norovirus Ag [Presence] in Stool

1.50

0.59

1.2

1.4

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

463

1.19

0.59

4.1

3.9

—

(3001556) Androgen free Index in Serum or Plasma

1.54

0.59

1.3

1.1

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

0.00

0.59

0.0

1.2

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

116

1034

1.12

0.59

1.6

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

114

1.40

0.58

1.4

1.1

—

(3047189) Immunofixation for 24 hour Urine

228

1.27

0.58

1.3

1.8

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

159

1445

1.10

0.58

1.3

1.2

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

309

1.23

0.58

1.3

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.71

0.57

1.0

1.1

—

(3016750) Collection duration of Urine

256

1.25

0.56

2.4

2.2

503.78

496.71

min

0.18

187

(3000093) Morphology [Interpretation] in Blood Narrative

457

1.18

0.56

1.1

—

(3012898) Urea [Moles/volume] in Urine

1.46

0.56

1.3

1.4

122.86

167.60

mmol/l

—

(40768806) Pleura Pathology biopsy report

462

0.82

0.56

1.7

1.6

—

(3022475) Manganese [Moles/volume] in Blood

1.62

0.55

1.2

1.3

0.18

0.16

umol/l

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

879

1.13

0.55

1.1

57.97

14009.68

iu/ml

0.61

186

(3001729) Color of Synovial fluid

1.58

0.54

1.8

1.5

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

655

6828

0.95

0.54

2.0

1.9

3.39

ratio

0.04

488

5154

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

1.54

0.53

1.0

1.1

—

27.80

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.54

0.53

2.2

1.9

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

108

1.39

0.53

1.6

1.3

1.18

mmol/l

0.07

108

(3006653) Thiamine [Moles/volume] in Blood

304

1.22

0.52

1.3

139.68

132.66

nmol/l

0.37

304

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

338

0.80

0.52

1.2

3.3

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.43

0.52

1.2

1.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

114

1026

1.11

0.52

3.5

2.0

0.86

0.85

nmol/l

0.05

880

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

315

1.21

0.50

1.3

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

152

1658

0.91

0.50

1.5

1.6

—

(3001893) Eosinophils/Leukocytes in Pleural fluid

127

1.34

0.49

1.2

1.6

2.77

2.95

0.03

114

(3034426) Prothrombin time (PT)

180

1.28

0.49

1.1

1.2

28.57

28.16

0.16

180

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

145

1.31

0.48

1.0

1.1

26.87

38.21

iu/ml

0.46

145

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.49

0.47

1.0

1.1

3.71

14.91

u/l

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.47

0.47

1.6

1.2

5.23

5.72

mmol/l

—

(3044009) aPTT.lupus sensitive (LA screen)

1.46

0.46

1.0

1.2

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

337

1.19

0.46

1.4

1.5

77.40

76.42

umol/l

0.09

337

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.45

0.44

3.5

1.9

—

(3022621) pH of Urine by Test strip

470

4502

1.05

0.43

2.8

2.5

6.04

6.10

0.75

298

2919

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

1.61

0.43

1.0

1.3

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

114

1041

1.10

0.42

3.5

3.3

20.60

25.77

mg/l

1.11

720

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.56

0.42

8.6

8.5

—

(3024869) Neuronal Ab [Presence] in Serum

1.38

0.42

1.0

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

134

1234

1.09

0.41

1.4

1.5

0.44

0.40

nmol/l

0.18

100

946

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

1.52

0.41

1.0

1.1

9.43

8.38

mmol/l

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

0.41

0.0

1.3

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.41

0.0

1.2

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.47

0.40

1.0

1.1

—

(4211845) Urine protein measurement

282

0.81

0.40

4.4

3.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.33

0.40

1.1

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

491

5106

0.96

0.40

1.7

3.42

3.49

mmol/l

0.62

327

3468

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.31

0.39

1.0

1.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

354

1.16

0.38

1.6

1.5

6.00

5.83

u/l

0.03

289

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.34

0.38

1.2

1.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

188

1.22

0.37

1.6

1.8

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

188

1.22

0.37

1.6

1.8

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

336

1.16

0.37

1.0

361.79

324.24

ng/l

0.25

240

(3041672) Baker's yeast Ab [Presence] in Serum

1.35

0.37

1.0

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.35

0.37

1.4

1.1

—

(3011288) Drugs identified in Urine by Screen method Nominal

158

1690

0.93

0.36

1.5

2.8

—

(3023383) Lactate [Moles/volume] in Pleural fluid

134

0.75

0.34

1.7

1.4

2.70

3.46

mmol/l

—

120

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

190

1.21

0.34

1.7

1.8

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

233

0.81

0.34

1.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

458

0.87

0.34

1.6

1.5

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.36

0.34

1.0

1.2

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

339

1.15

0.34

1.0

748.54

724.97

ng/l

0.10

235

(3045788) Cell count panel - Pleural fluid

447

0.87

0.34

1.4

1.5

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.33

0.33

2.0

1.4

42.17

46.53

umol/l

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

237

1.18

0.33

1.1

30.85

329.20

ng/l

—

(21494755) Public health laboratory ask at order entry panel

553

5709

0.97

0.33

1.3

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

118

1.27

0.33

1.1

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

341

1.14

0.32

1.0

47.84

42.33

ng/l

0.24

239

(3036071) Salmonella sp Ab [Titer] in Serum

201

1.19

0.32

1.0

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

445

1.12

0.32

1.2

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

408

1.13

0.31

1.5

1.4

391.61

347.09

u/l

0.21

390

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

202

1.19

0.31

1.8

41.37

40.65

g/l

0.24

202

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

131

0.76

0.30

1.4

1.3

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.27

0.30

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.27

0.30

2.1

2.6

—

(3035320) C reactive protein [Mass/volume] in Body fluid

429

1.12

0.29

3.1

2.6

19.52

27.16

mg/l

1.20

311

(3009466) Valproate [Moles/volume] in Serum or Plasma

691

0.91

0.28

4.0

5.5

350.80

369.04

umol/l

0.45

609

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

294

2824

1.04

0.28

10.4

10.5

15.77

15.98

0.64

281

2721

(3027456) Digoxin [Moles/volume] in Serum or Plasma

777

1.08

0.27

2.9

3.4

0.87

0.82

nmol/l

0.35

625

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

140

1.21

0.27

1.1

—

(4094501) Cardiovascular stress test using bicycle ergometer

155

1468

1.06

0.27

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

104

1.25

0.26

1.2

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

0.70

0.26

1.0

1.5

141.20

121.21

ug/l

—

(3020491) Glucose [Moles/volume] in Blood

388

1.11

0.24

2.1

1.6

6.73

6.31

mmol/l

0.48

277

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

102

959

1.06

0.23

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

102

959

1.06

0.23

1.3

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.28

0.23

1.0

0.00

0.11

u/ml

—

(4212803) Bone marrow aspirate examination

1.25

0.22

1.4

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.74

0.22

1.1

—

(40768795) Lymph node Pathology biopsy report

566

0.92

0.22

1.3

1.2

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

506

1.09

0.22

1.1

1.4

—

(3035880) pH of Pleural fluid

238

1.14

0.22

1.3

1.4

7.41

0.04

159

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

120

1265

0.95

0.22

1.5

64.92

60.56

ug/l

0.28

120

1265

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.21

0.0

5.5

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

2331.91

—

(3036180) Methadone [Presence] in Urine

0.00

0.21

0.0

2.9

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.7

—

1.77

—

(37019676) Renin [Units/volume] in Plasma --supine

0.00

0.21

0.0

1.0

—

11.94

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

103

0.78

0.21

2.4

3.3

80.38

2022.53

u/l

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.0

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

297

1.11

0.20

1.1

1.2

—

(3009208) Meadow Fescue IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.1

—

13.04

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.18

0.19

1.7

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.13

0.18

1.3

1.1

112.00

89.96

titre

—

(3006462) Nitrate [Presence] in Urine

258

0.89

0.17

4.4

3.2

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.15

0.17

1.4

1.3

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1371

13562

1.01

0.17

2.3

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

129

1.16

0.17

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

0.74

0.17

1.2

1.0

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

127

1218

1.04

0.16

2.0

2.2

127.99

128.70

g/l

0.12

101

960

(3000991) Gas panel - Venous blood

438

4290

1.02

0.16

11.1

9.3

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

427

1.08

0.16

1.5

1.6

1.24

1.14

promille

0.19

338

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

577

0.94

0.16

1.8

2.0

14.43

26.87

ug/l

4.74

567

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

183

0.87

0.16

1.1

68.22

59.52

u/ml

0.17

177

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

0.77

0.15

1.2

1.6

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

140

1.14

0.15

1.1

1.0

—

(3044242) Glucose [Moles/volume] in Arterial blood

265

1.09

0.14

1.8

2.0

7.21

8.05

mmol/l

1.03

265

(3004775) Volume in Urine collected for unspecified duration

343

1.08

0.14

2.6

2.3

708.44

612.63

0.68

225

(3028717) Thiamine [Mass/volume] in Blood

0.83

0.13

1.3

53.87

64.53

ug/l

—

(3023199) Leukocytes [#/volume] in Pleural fluid

531

0.94

0.13

1.5

2447.65

3693.29

e6/l

0.31

375

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

451

1.06

0.13

2.9

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

142

1.13

0.12

2.8

3.3

51.57

122.71

ng/l

—

(3035285) Chloride [Moles/volume] in Venous blood

477

0.94

0.12

3.5

2.3

106.22

105.34

mmol/l

0.69

470

(3041354) Potassium [Moles/volume] in Venous blood

477

0.94

0.12

3.5

2.3

3.93

4.01

mmol/l

0.77

470

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

143

1.12

0.11

1.1

1.0

—

(3043410) Blood group antigens tested for on Red Blood Cells

147

0.88

0.11

1.8

1.7

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

529

5361

0.99

0.11

3.2

4.2

10.38

31.67

ug/l

1.79

398

4263

(1761482) Bacteria [#/volume] in Urine by Culture

102

1053

0.97

0.10

4.8

4.0

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

293

2980

0.98

0.10

9.3

10.0

24.37

24.25

mmol/l

0.25

286

2937

(3050794) Legionella sp Ab [Presence] in Serum

1.04

0.09

1.0

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

252

1.07

0.09

1.1

—

0.12

—

(3014891) Appearance of Pleural fluid

1.11

0.09

3.5

1.6

—

(3042517) Benzodiazepines panel - Urine

1.11

0.09

1.2

2.3

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.11

0.09

1.3

1.0

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

1.07

0.08

9.3

6.1

6.83

8.73

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

1.07

0.08

4.7

3.0

42.33

43.32

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

210

2137

0.98

0.08

1.1

0.62

ratio

0.02

277

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

411

1.05

0.08

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.03

0.07

1.0

—

(40758292) HTLV I+II Ab panel - Serum

111

0.90

0.06

1.3

—

(1617658) Protocol used for examination of sentinel lymph nodes

487

0.96

0.06

1.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

466

0.97

0.05

3.5

2.3

1.20

mmol/l

0.30

459

(3003694) ABO and Rh group [Type] in Blood

1641

16469

1.00

0.05

1.5

—

(4146454) Self-monitoring of blood glucose

505

0.97

0.05

3.0

2.7

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

587

1.02

0.03

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

944

0.98

0.03

1.5

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

187

1887

0.99

0.03

3.2

3.5

71.08

2837.90

u/ml

1.19

162

1628

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

390

1.03

0.02

1.1

1.4

—

(4133840) Spirometry

128

0.94

0.02

1.0

1.2

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

251

1.04

0.02

1.3

2.1

96.92

155.99

umol/l

0.76

141

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

302

3036

0.99

0.02

1.7

—

(3003434) Protein [Mass/volume] in Pleural fluid

590

0.98

0.02

1.5

31.70

32.94

g/l

0.31

536

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

143

1.05

0.01

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

809

0.99

0.01

1.3

1.4

7.23

7.17

mmol/l

0.06

730

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

147

1479

0.99

0.01

1.7

1.8

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

114

1.05

0.00

1.5

1.2

4.28

368.44

ug/l

—

(3044007) Cell count panel - Peritoneal fluid

162

0.99

0.00

2.2

2.0

—

(3017569) Oxygen content in Arterial blood

268

1.01

0.00

2.3

2.2

16.93

16.11

0.64

268

(3028308) Erythrocytes [#/volume] in Pleural fluid

458

1.00

0.00

1.5

16221.57

78650.54

e6/l

2.40

256

(3020650) Glucose [Presence] in Urine

205

1.02

0.00

1.2

1.7

0.00

0.04

estimate

1.08

205

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

163

0.98

0.00

1.6

2.0

3694.00

17301.90

e6/l

—

(3039443) Prostate specific Ag panel - Serum or Plasma

604

0.99

0.00

1.7

1.6

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

303

0.99

0.00

1.9

1.5

1.22

1.30

nmol/l

0.16

224

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

131

0.99

0.00

2.5

2.1

13.08

17.11

umol/l

0.89

131

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

381

1.00

0.00

2.1

2.0

3.45

1.42

u/field

1.07

199

(3012441) Differential panel - Pleural fluid

441

1.00

0.00

1.6

1.5

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

0.90

0.00

1.2

1.1

—

(40757373) Influenza virus identified in Isolate

1.00

0.00

3.0

1.6

—

(3002022) Protein C Ag actual/normal in Platelet poor plasma by Immunoassay

0.00

0.0

1.2

—

57.20

—

(3008343) Lysozyme [Mass/volume] in Urine

0.00

0.0

1.0

—

0.46

—

(3025830) Chlamydophila pneumoniae IgM Ab [Units/volume] in Serum

0.00

0.0

1.0

—

19.20

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

0.00

0.0

1.2

—

1.20

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

2.0

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.00

0.0

1.2

—

167.40

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3009992) Blasts/cells in Bone marrow

0.00

0.0

2.0

—

6.40

—

(3034092) Cytoplasmic Ig cells/cells in Blood

0.97

-0.00

4.0

8.9

0.23

0.18

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

-0.00

0.0

1.4

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.00

-0.00

2.0

1.5

—

(3004451) EKG impression Narrative

280

1.00

-0.00

1.4

1.3

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.02

-0.00

1.0

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.02

-0.00

1.0

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

0.98

-0.00

1.0

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

1.02

-0.00

1.2

1.8

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.02

-0.00

1.3

1.5

—

(3051101) Glucose [Moles/volume] in Cord blood

1.00

-0.00

3.1

6.4

8.01

8.27

mmol/l

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

-0.00

0.0

1.1

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.91

-0.00

1.2

1.1

7.09

6.22

u/ml

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

-0.00

0.0

1.0

—

(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

44.98

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: L12_ROSACEA – Rosacea

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Rosacea

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Rosacea (L12_ROSACEA)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints